Energous (WATT) 10-K 15 Mar 16 2015 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Mar. 10, 2016	Jun. 30, 2015
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Entity Registrant Name	Energous Corp
Entity Central Index Key	1,575,793
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Public Float			$ 84,664,580
Trading Symbol	WATT
Entity Common Stock, Shares Outstanding		16,409,739

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 29,872,564	$ 31,494,592
Prepaid expenses and other current assets	722,249	416,580
Prepaid rent, current	80,784	80,784
Total current assets	30,675,597	31,991,956
Property and equipment, net	1,730,365	1,515,299
Prepaid rent, non-current	218,236	299,020
Other assets	51,330	22,648
Total assets	32,675,528	33,828,923
Current liabilities:
Accounts payable	2,324,973	1,716,011
Accrued expenses	1,075,879	792,349
Total current liabilities	$ 3,400,852	$ 2,508,360
Commitments and contingencies
Stockholders’ equity
Preferred Stock, $0.00001 par value, 10,000,000 shares authorized at December 31, 2015 and 2014; no shares issued or outstanding	$ 0	$ 0
Common Stock, $0.00001 par value, 50,000,000 shares authorized at December 31, 2015 and 2014; 16,298,208 and 12,781,502 shares issued and outstanding at December 31, 2015 and December 31, 2014, respectively.	161	127
Additional paid-in capital	107,981,695	82,465,914
Accumulated deficit	(78,707,180)	(51,145,478)
Total stockholders’ equity	29,274,676	31,320,563
Total liabilities and stockholders’ equity	$ 32,675,528	$ 33,828,923

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	16,298,208	12,781,502
Common stock, shares outstanding	16,298,208	12,781,502

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenue:
Revenue	$ 2,500,000	$ 0	$ 0
Operating expenses:
Derivative instrument issuance	0	0	887,062
Research and development	18,825,041	12,511,647	2,109,890
Sales and marketing	3,221,303	2,803,359	233,622
General and administrative	8,030,995	5,059,703	1,204,896
Total operating expenses	30,077,339	20,374,709	4,435,470
Loss from operations	(27,577,339)	(20,374,709)	(4,435,470)
Other income (expenses):
Change in fair value of derivative liabilities	0	(26,265,177)	(177,000)
Interest income (expense), net	15,637	(1,024,774)	(908,611)
Loss on retirement of fixed assets	0	(22,818)	0
Gain on debt extinguishment	0	2,084,368	0
Total	15,637	(25,228,401)	(1,085,611)
Net loss	$ (27,561,702)	$ (45,603,110)	$ (5,521,081)
Basic and diluted loss per common share	$ (2.07)	$ (5.75)	$ (2.11)
Weighted average shares outstanding, basic and diluted	13,303,715	7,933,791	2,617,022

STATEMENT OF CHANGES IN STOCKHO

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Dec. 31, 2012	$ (11,287)	$ 19	$ 9,981	$ (21,287)
Balance (in shares) at Dec. 31, 2012		1,924,813
Issuance of shares for services, net of commission expense	0
Stock-based compensation - stock options	16,148	$ 0	16,148	0
Issuance of Restricted common stock	35,464	$ 1	35,463	0
Issuance of Restricted common stock (in shares)		88,882
Common stock sold on January 28, 2013 to founder at $0.0052 per share	417	$ 1	416	0
Common stock sold on January 28, 2013 to founder at $0.0052 per share (in shares)		80,201
Common stock sold on March 4, 2013 to affiliate of a director at $0.24 per share	160,000	$ 7	159,993	0
Common stock sold on March 4, 2013 to affiliate of a director at $0.24 per share (in shares)		668,338
Common stock sold on May 7, 2013 to third party investor at $0.24 per share	4,800	$ 0	4,800	0
Common stock sold on May 7, 2013 to third party investor at $0.24 per share (in shares)		20,051
Repurchase and retirement of restricted common stock from consultant on November 30, 2013 at $0.40 per share	(29,553)	$ (1)	(29,552)	0
Repurchase and retirement of restricted common stock from consultant on November 30, 2013 at $0.40 per share (in shares)		(74,068)
Extinguishment of derivative for consulting warrant and financing warrant on June 25, 2014	0
Net loss	(5,521,081)	$ 0	0	(5,521,081)
Balance at Dec. 31, 2013	(5,345,092)	$ 27	197,249	(5,542,368)
Balance (in shares) at Dec. 31, 2013		2,708,217
Issuance of shares for services, net of commission expense	900,000	$ 2	899,998	0
Issuance of shares for services, net of commission expense (in shares)		210,527
Stock-based compensation - stock options	1,333,943	$ 0	1,333,943	0
Stock-based compensation - IR warrants	263,972	0	263,972	0
Stock-based compensation - restricted stock units ("RSUs")	900,063	0	900,063	0
Stock-based compensation - shares issued to consultant for services rendered	50,000	$ 0	50,000	0
Stock-based compensation - shares issued to consultant for services rendered (in shares)		5,353
Initial public offering on April 2, 2014, net of underwriter's discount and offering costs of $2,816,149	24,783,851	$ 46	24,783,805	0
Initial public offering on April 2, 2014, net of underwriter's discount and offering costs of $2,816,149 (in shares)		4,600,000
Conversion of convertible notes on April 2, 2014	26,790,177	$ 19	26,790,158	0
Conversion of convertible notes on April 2, 2014 (in shares)		1,930,128
Sale of IPO underwriter warrant on April 2, 2014	1,000	$ 0	1,000	0
Extinguishment of derivative for consulting warrant and financing warrant on June 25, 2014	5,752,000	0	5,752,000	0
Shares issued to landlord for prepaid rent	500,000	$ 0	500,000	0
Shares issued to landlord for prepaid rent (in shares)		41,563
Secondary offering net of underwriter's discount and offering costs	20,993,759	$ 33	20,993,726	0
Secondary offering net of underwriter's discount and offering costs (in shares)		3,285,714
Net loss	(45,603,110)	$ 0	0	(45,603,110)
Balance at Dec. 31, 2014	31,320,563	$ 127	82,465,914	(51,145,478)
Balance (in shares) at Dec. 31, 2014		12,781,502
Issuance of shares for services, net of commission expense	147,900	$ 0	147,900	0
Issuance of shares for services, net of commission expense (in shares)		15,000
Stock-based compensation - stock options	1,037,399	$ 0	1,037,399	0
Stock-based compensation - IR warrants	85,831	0	85,831	0
Stock-based compensation - restricted stock units ("RSUs")	4,225,728	0	4,225,728	0
Stock-based compensation - employee stock purchase plan ("ESPP")	113,217	0	113,217	0
Stock-based compensation - performance share units ("PSUs")	489,239	0	489,239	0
Issuance of shares for PSUs	0	$ 0	0	0
Issuance of shares for PSUs (in shares)		1,072
Issuance of Restricted common stock	0	$ 3	(3)	0
Issuance of Restricted common stock (in shares)		304,340
Exercise of stock options	65,647	$ 0	65,647	0
Exercise of stock options (in shares)		21,786
Disgorgement on account of short swing profit	12,611	$ 0	12,611	0
Cashless exercise of warrants	0	$ 1	(1)	0
Cashless exercise of warrants (in shares)		128,480
Shares purchased from contributions to the ESPP		46,023
Shares purchased from contributions to the ESPP	289,787	$ 0	289,787	0
Extinguishment of derivative for consulting warrant and financing warrant on June 25, 2014	0
Secondary offering net of underwriter's discount and offering costs	19,048,456	$ 30	19,048,426	0
Secondary offering net of underwriter's discount and offering costs (in shares)		3,000,005
Net loss	(27,561,702)	$ 0	0	(27,561,702)
Balance at Dec. 31, 2015	$ 29,274,676	$ 161	$ 107,981,695	$ (78,707,180)
Balance (in shares) at Dec. 31, 2015		16,298,208

STATEMENT OF CHANGES IN STOCKH6

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Common Stock Issued To Third Party Investor Per Share Price			$ 0.24
Common Stock Issued To Founder Per Share Price			0.0052
Common Stock Issued To Affiliate Director Per Share Price			0.24
Restricted Common Stock Issued To Consultant Per Share Price			0.40
Repurchase And Retirement Of Restricted Common Stock From Consultant Per Share Price			$ 0.40
Payments of Stock Issuance Costs		$ 2,816,149
Partners' Capital Account, Public Sale of Units Net of Offering Costs	$ 1,651,578	$ 2,006,239

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net loss	$ (27,561,702)	$ (45,603,110)	$ (5,521,081)
Adjustments to reconcile net loss to Net cash used in operating activities:
Depreciation and amortization	817,729	371,189	4,717
Stock based compensation	5,951,414	2,547,978	16,148
Amortization of debt discount	0	964,851	705,289
Warrant expense	0	0	724,000
Write-off of abandoned trademark	0	0	4,725
Gain on conversion of notes payable and accrued interest	0	(2,084,368)	0
Change in fair market value of derivative liabilities	0	26,265,177	177,000
Loss on retirement of fixed assets	0	22,818	0
Amortization of prepaid rent from stock issuance to landlord	80,784	20,196	0
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(157,769)	(289,383)	(127,197)
Other assets	(28,682)	(15,689)	(6,959)
Accounts payable	608,962	1,354,973	359,163
Accrued expenses	283,530	838,945	233,217
Net cash used in operating activities	(20,005,734)	(15,606,423)	(3,430,978)
Cash flows used in investing activities:
Purchases of property and equipment	(1,032,795)	(1,619,694)	(194,329)
Costs of trademark	0	0	(4,725)
Net cash used in investing activities	(1,032,795)	(1,619,694)	(199,054)
Cash flows from financing activities:
Proceeds from the sale of common stock	0	0	200,681
Payment of deferred offering costs	0	0	(88,319)
Repurchase of restricted common stock	0	0	(29,553)
Proceeds from IPO, net of underwriter's discount and offering expenses	0	24,872,170	0
Proceeds from the sale of stock to strategic investor, net	0	900,000	0
Sale of Warrant to IPO underwriter	0	1,000	0
Proceeds from shares issued under shelf registration, net of underwriter's discount and offering expenses	19,048,456	0	0
Proceeds from the exercise of stock options	65,647	0	0
Proceeds from secondary offering, net of underwriter's discount and offering expenses	0	20,993,759	0
Proceeds from the sale of senior secured convertible notes			5,500,009
Proceeds from contributions to employee stock purchase plan	289,787	0	0
Proceeds from the disgorgement of short-swing profit	12,611	0	0
Net cash provided by financing activities	19,416,501	46,766,929	5,582,818
Net (decrease) increase in cash and cash equivalents	(1,622,028)	29,540,812	1,952,786
Cash and cash equivalents - beginning	31,494,592	1,953,780	994
Cash and cash equivalents - ending	29,872,564	31,494,592	1,953,780
Supplemental disclosure of non-cash financing activities:
Decrease in deferred offering costs charged to the IPO	0	88,319	0
Common stock issued upon conversion of notes payable and accrued interest payable	0	26,790,177	0
Increase in additional paid in capital upon extinguishment of derivative liability for warrants	0	5,752,000	0
Common stock issued to landlord for tenant improvement of $100,000 and prepaid rent of $400,000	0	500,000	0
Common stock issued for services	$ 147,900	$ 900,000	$ 0

STATEMENTS OF CASH FLOWS (Paren

STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Payments for Tenant Improvements	$ 100,000	$ 100,000
Payments for Rent		$ 400,000

Business Organization, Nature o

Business Organization, Nature of Operations	12 Months Ended
	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1 - Business Organization, Nature of Operations Energous Corporation (the “Company”) was incorporated in Delaware on October 30, 2012. The Company is developing a technology called WattUp® that consists of proprietary semiconductor chipsets, software, hardware designs and antennas that can enable RF-based wire-free charging for electronic devices, providing power at a distance and ultimately enabling charging with mobility under full software control. The Company’s anticipated business model is to supply silicon components with reference designs and license our WattUp technology to device and chip manufacturers, wireless service providers and other commercial partners to make wire-free charging an affordable, ubiquitous and convenient option for end users. The Company believes their proprietary technology can potentially be utilized in a variety of devices, including wearables, Internet of Things (IoT) devices, smartphones, tablets, e-book readers, keyboards, mice, remote controls, rechargeable lights, cylindrical batteries and any other device with similar charging requirements that would otherwise need a battery or a connection to a power outlet. The Company is developing solutions that charge electronic devices by surrounding them with a contained three dimensional (“3D”) radio frequency (“RF”) energy pocket (“RF energy pocket”). The Company is engineering solutions that are expected to enable the wire-free transmission of energy from multiple WattUp transmitters to multiple WattUp receiving devices within a range of up to fifteen (15) feet in radius or in a circular charging envelope of up to thirty (30) feet. The Company is also developing a transmitter technology to seamlessly mesh, (much like a network of WiFi routers) to form a wire-free charging network that will allow users to charge their devices as they walk from room-to-room or throughout a large space. To date, the Company has developed multiple transmitter prototypes in various form factors and power capabilities. The Company has also developed multiple receiver prototypes including smartphone battery cases, toys, fitness trackers, Bluetooth headsets as well as stand-alone receivers.

Liquidity and Management Plans

Liquidity and Management Plans	12 Months Ended
	Dec. 31, 2015
Liquidity And Management Plan Disclosure [Abstract]
Liquidity And Management Plan Disclosure [Text Block]	Note 2 – Liquidity and Management Plans During the year ended December 31, 2015, the Company has recorded revenue of $ 2,500,000 27,561,702 45,603,110 5,521,081 20,005,734 15,606,423 3,430,978 As of December 31, 2015, the Company had cash on hand of $ 29,872,564 4,600,000 24.8 1,833,336 96,792 210,527 900,000 300,000 700,000 100,000 3,285,714 21.0 75,000,000 3,000,005 19,048,456 Research and development of new technologies is, by its nature, unpredictable. Although the Company will undertake development efforts with commercially reasonable diligence, there can be no assurance that its available resources including the net proceeds from the Company’s IPO, secondary offering, issuance lender shelf registration, and strategic investor financing will be sufficient to enable it to develop and obtain regulatory approval of its technology to the extent needed to create future revenues sufficient to sustain its operations. The Company may choose to pursue additional financing, depending upon the market conditions, which could include follow-on equity offerings, debt financing, co-development agreements or other alternatives. Should the Company choose to pursue additional financing, there is no assurance that the Company would be able to do so on terms that it would find acceptable.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 3 – Summary of Significant Accounting Policies The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements as well as the reported expenses during the reporting periods. The Company’s significant estimates and assumptions include the valuation of stock-based compensation instruments, recognition of revenue, the useful lives of long-lived assets, and income tax expense. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Although the Company believes that its estimates and assumptions are reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ from those estimates. Certain amounts in prior periods have been reclassified to conform to the current period presentation. These reclassifications had no effect on previously reported net loss. The Company considers all short-term, highly liquid investments with an original maturity at the date of purchase of three months or less to be cash equivalents. The Company maintains cash balances that may be uninsured or in deposit accounts that exceed Federal Deposit Insurance Corporation limits. The Company maintains its cash deposits with major financial institutions. The Company recognizes revenue when all of the following criteria have been met: persuasive evidence of an arrangement exists, services have been rendered, collection of the revenue is reasonably assured, and the fees are fixed or determinable. The Company records revenue associated with product development projects that it enters into with certain customers. In general, these projects are associated with complex technology development, and as such the Company does not have certainty about its ability to achieve the program milestones. Achievement of the milestone is dependent on our performance and the milestone typically needs to be accepted by the customer. The payment associated with achieving the milestone is generally commensurate with the Company’s effort or the value of the deliverable and is nonrefundable. The Company records the expenses related to these projects, generally included in research and development expense, in the periods incurred. The Company also receives nonrefundable payments, typically at the beginning of a customer relationship, for which there are no milestones. The Company recognizes this revenue ratably over the initial engineering product development period. The Company records the expenses related to these projects, generally included in research and development expense, in the periods incurred. Research and development expenses are charged to operations as incurred. For internally developed patents, all patent application costs are expensed as incurred as research and development expense. Patent application costs, generally legal costs, are expensed as research and development costs until such time as the future economic benefits of such patents become more certain. The Company incurred research and development costs of $ 18,825,041 12,511,647 2,109,890 The Company accounts for equity instruments issued to employees in accordance with accounting guidance that requires awards to be recorded at their fair value on the date of grant and are amortized over the vesting period of the award. The Company recognizes compensation costs on a straight line basis over the requisite service period of the award, which is typically the vesting term of the equity instrument issued. On April 10, 2015, the Company’s board of directors approved the Energous Corporation Employee Stock Purchase Plan (the “ESPP”), under which 600,000 On May 21, 2015, the Company’s stockholders approved the ESPP. Under the plan, employees may purchase a limited number of shares of the Company’s common stock at a 15 Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of December 31, 2015, no liability for unrecognized tax benefits was required to be reported. The guidance also discusses the classification of related interest and penalties on income taxes. The Company’s policy is to record interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded during the years ended December 31, 2015, 2014 and 2013. Basic net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and warrants (using the treasury stock method), the vesting of restricted stock units (“RSUs”) and performance stock units (“PSUs”) and the enrollment of employees in the ESPP. The computation of diluted loss per share excludes potentially dilutive securities of 4,994,425 3,261,360 3,525,904 For the Years Ended December 31, 2015 2014 2013 Convertible Notes – principal - - 2,650,858 Convertible Notes – accrued interest - - 100,224 Consulting Warrant to purchase common stock 146,252 278,228 278,228 Financing Warrant to purchase common stock 152,778 152,778 220,905 IPO Warrants to purchase common stock 460,000 460,000 - IR Consulting Warrant 36,000 36,000 - IR Incentive Warrant 15,000 - - Options to purchase common stock 1,487,785 1,607,075 275,689 RSUs 1,560,996 727,279 - PSUs 1,135,614 - - Total potentially dilutive securities 4,994,425 3,261,360 3,525,904 The carrying amounts of cash and cash equivalents, accounts payable and accrued expenses, approximate fair value due to the short-term nature of these instruments. Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows: Level 1 Quoted prices in active markets for identical assets or liabilities. Level 2 Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly. Level 3 Significant unobservable inputs that cannot be corroborated by market data. The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. As of December 31, 2014, the Company no longer had financial instruments which were derivative liabilities. For the Year Ended Beginning balance $ 6,277,000 Change in fair value of conversion feature and warrants 26,265,177 Extinguishment of derivative liability upon conversion of Convertible Notes (26,790,177) Extinguishment of derivative liability upon modification of Financing Warrant (1,733,000) Extinguishment of derivative liability upon modification of Consulting Warrant (4,019,000) Ending balance $ - The conversion feature of the Convertible Notes immediately prior to conversion was measured at fair value using a Monte Carlo simulation (which also represented the intrinsic value of the conversion feature) and was classified within Level 3 of the valuation hierarchy. The warrant liabilities for the Financing Warrant and the Consulting Warrant, immediately prior to modification were measured at fair value using a Monte Carlo simulation and were classified within Level 3 of the valuation hierarchy. The significant assumptions and valuation methods that the Company used to determine fair value and the change in fair value of the Company’s derivative financial instruments are discussed in Note 6 – Private Placement. Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Interim Chief Financial Officer determined its valuation policies and procedures. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s Interim Chief Financial Officer with support from the Company’s consultants and which are approved by the Interim Chief Financial Officer. Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. The Company used a Monte Carlo model to value Level 3 financial liabilities at inception and on subsequent valuation dates, except that the conversion feature of the convertible notes immediately prior to conversion was valued at intrinsic value. This simulation incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as, volatility. The Company also used a binomial simulation and Black-Scholes economic model as supplemental valuation tools in order to validate the reasonableness of the results of the Monte Carlo simulation when measuring the Financing Warrant and the Consulting Warrant. A significant increase in the volatility or a significant increase in the Company’s stock price, in isolation, would result in a significantly higher fair value measurement. Changes in the values of the derivative liabilities were recorded in Change in Fair Value of Derivative Liabilities within Other Expense (Income) on the Company’s Statements of Operations. Management determined that the results of its valuations are reasonable. In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers" (Topic 606), which supersedes the revenue recognition requirements in ASC Topic 605, "Revenue Recognition," and most industry-specific guidance. This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. The amendments in the ASU must be applied using one of two retrospective methods and are effective for annual and interim periods beginning after December 15, 2016. On July 9, 2015, the FASB modified ASU 2014-09 to be effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. As modified, the FASB permits the adoption of the new revenue standard early, but not before the annual periods beginning after December 15, 2016. A public organization would apply the new revenue standard to all interim reporting periods within the year of adoption. The Company will evaluate the effects, if any, that adoption of this guidance will have on its financial statements. In August 2014, FASB issued ASU No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This standard is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. Under U.S. GAAP, financial statements are prepared under the presumption that the reporting organization will continue to operate as a going concern, except in limited circumstances. Financial reporting under this presumption is commonly referred to as the going concern basis of accounting. The going concern basis of accounting is critical to financial reporting because it establishes the fundamental basis for measuring and classifying assets and liabilities. Currently, U.S. GAAP lacks guidance about management’s responsibility to evaluate whether there is substantial doubt about the organization’s ability to continue as a going concern or to provide related footnote disclosures. This ASU provides guidance to an organization’s management, with principles and definitions that are intended to reduce diversity in the timing and content of disclosures that are commonly provided by organizations today in the financial statement footnotes. The amendments are effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early application is permitted for annual or interim reporting periods for which the financial statements have not previously been issued. The adoption of this standard is not expected to have a material impact on the Company’s financial position and results of operations. In April 2015, the FASB issued ASU No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs." This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of a deferred charge. It is effective for annual reporting periods beginning after December 15, 2015, but early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s financial position and results of operations. In August 2015, the FASB issued ASU No. 2015-15, “Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements” – Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015, which clarified the SEC staff’s position on presenting and measuring debt issuance costs incurred in connection with line-of-credit arrangements. ASU 2015-15 should be adopted concurrent with the adoption of ASU 2015-03. The adoption of this standard is not expected to have a material impact on the Company’s financial position and results of operations. In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes” (“ASU 2015-17”). The standard requires that deferred tax assets and liabilities be classified as noncurrent in a classified statement of financial position. ASU 2015-17 is effective for fiscal years and interim periods within those years, beginning after December 15, 2016. Early adoption is permitted. ASU 2015-17 may be applied either prospectively, for all deferred tax assets and liabilities, or retrospectively. The Company is currently evaluating the impact this standard will have on its financial statements. In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). The standard addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. ASU 2016-01 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company is currently evaluating the impact the adoption of this new standard will have on its financial statements. In January 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842).” (“ASU 2016-02”) Management’s Evaluation of Subsequent Events The Company evaluates events that have occurred after the balance sheet date of December 31, 2015, through the date which the financial statements are issued. Based upon the review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 4 – Property and Equipment As of December 31, 2015 2014 Computer software $ 650,386 $ 459,861 Computer hardware 1,203,021 725,739 Furniture and fixtures 457,887 342,452 Leasehold improvements 593,287 343,734 2,904,581 1,871,786 Less – accumulated depreciation (1,174,216) (356,487) Total property and equipment, net $ 1,730,365 $ 1,515,299 Total depreciation and amortization expense of the Company’s property and equipment was $ 817,729 371,189 4,717

Accrued Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2015
Payables and Accruals [Abstract]
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	Note 5 – Accrued Expenses As of December 31, 2015 2014 Accrued compensation $ 739,782 $ 425,824 Other accrued expenses 336,097 366,525 Total $ 1,075,879 $ 792,349

Private Placement

Private Placement	12 Months Ended
	Dec. 31, 2015
Private Placement [Abstract]
Private Placement [Text Block]	Note 6 – Private Placement Senior Secured Convertible Notes On May 16, 2013, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors (the “Investors”), pursuant to which the Company sold an aggregate of $ 5,500,009 May 16, 2013 6 August 16, 2014 In connection with the funding of the IPO, on April 2, 2014, the principal and interest due under the Convertible Notes of $ 5,500,009 290,219 1,833,336 96,792 Accounting for the Senior Secured Convertible Notes Pursuant to the terms of the Convertible Notes, the conversion price was subject to adjustment in the event of an IPO, other financing and upon certain other events. The embedded conversion feature was not clearly and closely related to the host instrument and was bifurcated from the host Convertible Notes as a derivative, principally because the instrument’s variable exercise price terms would not qualify as being indexed to the Company’s own common stock. Accordingly, through April 1, 2014, this conversion feature instrument was classified as a derivative liability. Derivative liabilities are initially recorded at fair value and are then re-valued at each reporting date, with changes in fair value recognized in earnings during the reporting period. As of April 2, 2014 Stock price on valuation date $ 13.88 Conversion price $ 3.00 Fair value $ 26,790,177 The amortization of debt discount related to the Convertible Notes was $ 0 964,851 705,289 0 21,217,177 197,000 1,833,336 96,792 2,084,368 1,930,128 26,790,177 Placement Agent Agreement On January 23, 2013, the Company entered into an agreement (the “Placement Agent Agreement”) with MDB Capital Group, Inc. (“MDB”), pursuant to which the Company appointed MDB to act as the Company’s placement agent in connection with the sale of the Company’s securities (“Offering or Offerings”). Specifically, MDB was the placement agent in connection with the sale of its Convertible Notes. In connection with the sale of the Convertible Notes, the Company paid MDB a cash fee of $ 538,393 1,000 550,000 3.60 120 3.00 152,778 3.60 120 3.00 As originally executed and through June 24, 2014, in the event of a non-liquid exit transaction, as defined in the Financing Warrant agreement, the holder of the Financing Warrant could have put the Financing Warrant back to the Company for a cash settlement at a fair value amount that would be determined by appraisal and agreed to by both parties (the “Financing Warrant Put”). On June 25, 2014, the Financing Warrant was modified to remove the Financing Warrant put feature. MDB shall have certain registration rights with respect to the common stock issued upon exercise of the Financing Warrant, including a onetime demand registration right with respect to such common stock. Consulting Agreement On January 23, 2013, the Company entered into a consulting agreement with MDB (the “Consulting Agreement”), pursuant to which MDB agreed to provide financial, strategic and intellectual property advisory services. The Consulting Agreement had an initial term of 180 days, and was renewed automatically upon the expiration of its initial term, after which it will continue in effect until it is terminated by either party with 30 days written notice to the other party. On July 11, 2014, the Company provided notice to MDB of its termination of the Consulting Agreement. As consideration for services provided under the Consulting Agreement prior to May 16, 2013, the Company sold to MDB for $ 1,500 278,228 0.04 MDB shall have certain registration rights with respect to the common stock issued upon exercise of the Consulting Warrant, including a onetime demand registration right with respect to such common stock. Accounting for the Financing Warrant and the Consulting Warrant The Company determined that due to their cash settlement features, as originally issued, both the Financing Warrant and the Consulting Warrant qualified as derivative instruments. Accordingly, upon issuance, these instruments were classified as derivative liabilities. Derivative liabilities are initially recorded at fair value and are then re-valued at each reporting date, with changes in fair value recognized in earnings during the reporting period. Effective on June 25, 2014, upon the removal of the cash settlement put features within the Financing Warrant and the Consulting Warrant, (as discussed above), each of the Consulting Warrant and the Financing Warrant no longer qualified as derivative instruments. Accordingly, on June 25, 2014, after first recording a mark-to-market adjustment to fair value, the aggregate fair value of $ 5,752,000 The Company calculated the fair value of the Financing Warrant and the Consulting Warrant using a Monte Carlo simulation, with the observable assumptions as provided in the table below. The significant unobservable inputs used in the fair value measurement of the reporting entity’s Financing Warrant and the Consulting Warrant are expected stock prices, levels of trading and liquidity of the Company’s common stock. Significant increases in the expected stock prices and expected liquidity would result in a significantly higher fair value measurement. Significant increases in either the probability or severity of default of the host instrument would result in a significantly lower fair value measurement. As of June 24, 2014 As of December 31, 2013 Financing Consulting Financing Consulting Stock price on valuation date $ 14.69 $ 14.69 $ 1.68 $ 1.68 Exercise price $ 3.60 $ 0.04 $ 2.49 $ 0.04 Term (years) 3.89 3.89 4.38 4.38 Expected volatility 60 % 60 % 60 % 60 % Dividend yield 0 % 0 % 0 % 0 % Weighted average risk-free interest rate 1.33 % 1.33 % 1.75 % 1.75 % Number of warrants 152,778 278,228 220,905 278,228 Number of trials 20,000 20,000 20,000 20,000 Aggregate fair value $ 1,733,000 $ 4,019,000 $ 175,000 $ 529,000 During the years ended December 31, 2014 and 2013, the Company recorded an increase of $ 5,048,000 20,000

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 7 – Commitments and Contingencies Investor Relations Agreements Effective January 13, 2014 8,000 36,000 7.80 130 3,000 3,000 15,000 7.80 250,000 th As of December 31, 2015 and 2014, 36,000 34,800 7,522 263,972 As of December 31, 2014 a total of 15,000 92,000 15,000 78,309 On February 4, 2015, the Company entered into a six-month consulting agreement with a consultant to provide the Company with investor relations services. Compensation under the agreement included the Company’s issuance on February 26, 2015, of 15,000 147,900 5,000 147,900 Operating Leases On September 10, 2014, the Company entered into a Lease Agreement (the “Lease”) with Balzer Family Investments, L.P. (the “Landlord”) related to space located at Northpointe Business Center, 3590 North First Street, San Jose, California. The initial term of the lease is 60 36,720 41,563 500,000 400,000 6,732 100,000 400,000 100,000 On February 26, 2015, the Company entered into a sub-lease agreement for additional space in the San Jose area. The agreement has a term which expires on June 30, 2019 and an initial monthly rent of $ 6,109 4,314 On July 9, 2015, the Company entered into a sub-lease agreement for additional space in Costa Mesa, CA. The agreement has a term which expires on September 30, 2017 and a monthly rent of $ 6,376 For the Years Ended December 31, Amount 2016 529,309 2017 572,722 2018 530,531 2019 372,652 Total $ 2,005,214 Development and Licensing Agreement Effective January 28, 2015, the Company signed a development and licensing agreement with a consumer electronics company to embed WattUp wire-free charging receiver technology in various products including, but not limited to certain mobile consumer electronics and related accessories. During the development phase and through customer shipment of their first product, Energous will afford this customer an exclusive “time to market advantage” in the licensed product categories. This development and licensing agreement contains both invention and development milestones that the Company will need to achieve during the next two years. Pursuant to the Agreement, on March 23, 2015, the Company received an initial non-refundable payment of $ 500,000 2,000,000 Effective April 3, 2015, the Company entered into an amendment of the development and license agreement with this consumer electronics company to include joint development of wire-free transmitter technology and technology license back to the Company. On June 5, 2015, the Company entered into a second amendment of the development and license agreement with this consumer electronics company to conform the agreement for technical changes in the product delivery milestones. Effective October 1, 2015, the Company entered into a third amendment of the development and license agreement with this consumer electronics company to make certain changes to, among other things, payment terms and the products covered by the agreement. Hosted Design Solution Agreement On June 25, 2015, the Company entered into a three-year agreement to license electronic design automation software in a hosted environment. Pursuant to the agreement, under which services began July 13, 2015, the Company is required to remit quarterly payments in the amount of $ 100,568 198,105 Amended Employee Agreement – Stephen Rizzone On April 3, 2015, the Company entered into an Amended and Restated Executive Employment Agreement with Stephen R. Rizzone, the Company’s President and Chief Executive Officer (the “Employment Agreement”). The Employment Agreement has an effective date of January 1, 2015 and an initial term of four years (the “Initial Employment Period”). The Employment Agreement provides for an annual base salary of $ 365,000 100 Pursuant to Mr. Rizzone’s prior employment agreement, on December 12, 2013 Mr. Rizzone was granted a ten year option to purchase 275,689 1.68 48 496,546 6.00 Effective with the approval on May 21, 2015 by the Company’s stockholders of its new performance-based equity plan, the Employment Agreement provided and Mr. Rizzone received, a grant of 639,075 100 1.1 100 50 50 Mr. Rizzone is also eligible to receive all customary and usual benefits generally available to senior executives of the Company. The Employment Agreement provides that if Mr. Rizzone’s employment is terminated due to his death or disability, if Mr. Rizzone’s employment is terminated by the Company without cause or if he resigns for good reason, twenty-five percent ( 25 100 Offer Letter – Brian Sereda Effective July 13, 2015, the Company appointed Brian Sereda to serve as Vice President and Chief Financial Officer, replacing Interim Chief Financial Officer Howard Yeaton. In connection with Mr. Sereda’s appointment as Vice President and Chief Financial Officer, the Company and Mr. Sereda executed an offer letter effective July 13, 2015 (the “Sereda Offer Letter”). Under the Sereda Offer Letter, Mr. Sereda will receive an annual base salary of $ 250,000 75 120,000 In the event Mr. Sereda is terminated without cause, he is entitled to (1) six months of his then-current base salary and (2) payment of COBRA premiums for up to six months. In the event of a liquidation event and termination of employment, except for cause, 100% of the inducement award shall immediately vest. Consulting Arrangement On October 5, 2015, George B. Holmes resigned as Chief Commercial Officer of the Company. Mr. Holmes will provide consulting services to the Company pursuant to a six month consulting agreement pursuant to which he will receive consulting fees totaling $ 80,000 80,201 2.49 44,836

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2015
Stockholders Equity Note [Abstract]
Stockholders Equity Note Disclosure [Text Block]	Note 8 – Stockholders’ Equity Authorized Capital The holders of the Company’s common stock are entitled to one vote per share. Holders of common stock are entitled to receive ratably such dividends, if any, as may be declared by the board of directors out of legally available funds. Upon the liquidation, dissolution or winding up of the Company, holders of common stock are entitled to share ratably in all assets of the Company that are legally available for distribution. Sale of Common Stock The Company entered into a stock purchase agreement dated March 7, 2014, under which a strategic investor (‘Strategic Investor”) agreed to purchase 210,527 0.0001 1,000,000 210,527 1,000,000 300,000 700,000 100,000 Amendment to Certificate of Incorporation On March 26, 2014, the Company’s board of directors and stockholders approved the Second Amended and Restated Certificate of Incorporation which increased the authorized shares to 60,000,000 10,000,000 Initial Public Offering The registration statement for the Company’s IPO was declared effective on March 27, 2014. On April 2, 2014, the Company consummated the Public Offering of 4,600,000 600,000 6.00 25,214,596 2,208,000 177,404 430,745 24,783,851 IPO Underwriter Warrant Simultaneous with the funding of the IPO, the Company issued to the underwriter a warrant to purchase 460,000 7.50 Secondary Offering The registration statement for the Company’s Secondary Offering was declared effective on December 15, 2014. On December 15, 2014, the Company consummated the Public Offering of 3,285,714 7.00 21,239,998 1,610,000 150,000 246,239 20,993,759 Disgorgement of Short Swing Profits On April 11, 2015, $ 12,611 Consummation of Offering under Shelf Registration On April 24, 2015, the Company filed a “shelf” registration statement on Form S-3, which became effective on April 30, 2015. The “shelf” registration statement allows the Company from time to time to sell any combination of debt or equity securities described in the registration statement up to aggregate proceeds of $ 75,000,000 Pursuant to the shelf registration, on November 17, 2015, the Company consummated an offering of 3,000,005 6.90 19,333,032 1,242,002 125,000 284,576 19,048,456

Stock Based Compensation

Stock Based Compensation	12 Months Ended
	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 9 – Stock Based Compensation Equity Incentive Plans 2013 Equity Incentive Plan In December 2013 the Company’s board and stockholders approved the “2013 Equity Incentive Plan”, providing for the issuance of equity based instruments covering up to an initial total of 1,042,167 2,335,967 Effective on March 10, 2014, the Company’s board of directors and stockholders approved the First Amendment to the 2013 Equity Incentive Plan which provided for an increase in the aggregate number of shares of common stock that may be issued pursuant to the Plan to equal 18% of the total number of shares of common stock outstanding immediately following the completion of the IPO (assuming for this purpose the issuance of all shares issuable under the Company’s equity plans, the conversion into common stock of all outstanding securities that are convertible by their terms into common stock and the exercise of all options and warrants exercisable for shares of common stock and including shares and warrants issued to the underwriters for such IPO upon exercise of its over-allotment options). As of December 31, 2015, 185,827 2014 Non-Employee Equity Compensation Plan On March 6, 2014, the Company’s board of directors and stockholders approved the 2014 Non-Employee Equity Compensation Plan for the issuance of equity-based instruments covering up to 250,000 As of December 31, 2015, 136,808 2015 Performance Share Unit Plan On April 10, 2015, the Company’s board of directors approved the Energous Corporation 2015 Performance Share Unit Plan (the “Performance Share Plan”), under which 1,310,104 As of December 31, 2015, 31,951 Employee Stock Purchase Plan On April 10, 2015, the Company’s board of directors approved the ESPP, under which 600,000 As of December 31, 2015, 553,977 289,787 On December 31, 2015, a total of 46,023 shares were then delivered to the participating employees. Stock Options On January 7, 2014, the Company’s board of directors granted to various employees and consultants from the 2013 Equity Incentive Plan stock options to purchase an aggregate of 537,845 2.49 57,644 80,201 319,799 3/48ths on the date of grant, and will vest 1/48th monthly over the following 45 months vested 25% on October 1, 2014 and then continues to vest 1/48th of the initial award monthly for the subsequent 36 months. vest 25% of the award on the later of the first anniversary of the date they started working for the Company or October 1, 2014 and then will vest 1/48th of the initial award monthly for the following 36 months 762,699 On February 27, 2014, the Company granted non-qualified stock options for the purchase of 25,979 3.63 100,000 On March 15, 2014 and March 20, 2014, the Company granted non-qualified stock options from the 2014 Non-Employee Equity Compensation Plan for the purchase of an aggregate of 34,781 5.45 vest 25% on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014 100,000 On March 15, 2014, the Company’s board of directors granted to a single employee an option under the 2013 Equity Incentive Plan to purchase 80,201 4.99 vests 25% of the award on the anniversary of the employee’s date of hire and then will vest 1/48th of the initial award monthly during the following 36 months 229,365 On March 26, 2014, the Company’s board of directors granted to Mr. Rizzone, the Company’s Chief Executive Officer, an option under the 2013 Equity Incentive Plan to purchase 496,546 6.00 vests 6/48 of the award on the grant date and 1/48 of the award on the last day of each of the subsequent 42 months 1,667,784 On March 26, 2014, the Company’s board of directors granted to Michael Leabman, Chief Technical Officer, pursuant to his employment contract a stock option under the 2013 Equity Incentive Plan to purchase 251,474 6.00 vests 6/48th of the award on the grant date and 1/48th of the award on the last day of each of the subsequent 42 months 844,643 On March 26, 2014, the Company’s board of directors granted to Mr. Holmes a stock option under the 2013 Equity Incentive Plan to purchase 89,672 6.00 vested 25% of the award on September 30, 2014 and continues to vest 1/48th of the award on the last day of each of the subsequent 36 months 303,869 Option Grants Awarded During the Year Ended December 31, 2014 Stock price $2.49 to $6.00 Dividend yield 0 % Expected volatility 60 % Risk-free interest rate 1.30% to 2.03% Expected life 3.75 to 6.25 years For the year ended December 31, 2015, the Company did not issue any grants. Stock Option Award Activity Weighted Weighted Average Average Remaining Number of Exercise Life In Intrinsic Options Price Years Value Outstanding at January 1, 2015 1,607,075 $ 4.41 9.0 $ 10,467,374 Granted - - - - Exercised (21,786) 3.01 - - Forfeited (97,504) 5.72 - - Outstanding at December 31, 2015 1,487,785 $ 4.43 8.0 $ 5,310,340 Exercisable at December 31, 2015 860,970 $ 4.34 8.0 $ 3,076,767 As of December 31, 2015, the unamortized value of options was $ 1,676,416 1.8 The aggregate intrinsic value of options exercised was $ 92,728 0 No options were granted during the year ended December 31, 2015. The weighted average grant date fair value per share of options granted during the year ended December 31, 2014 was $ 2.60 Option Valuation The Company has computed the fair value of options granted using the Black-Scholes option pricing model. Option forfeitures are estimated at the time of valuation and reduce expense ratably over the vesting period. This estimate will be adjusted periodically based on the extent to which actual option forfeitures differ, or are expected to differ, from the previous estimate, when it is material. The expected term used for options issued to non-employees is the contractual life and the expected term used for options issued to employees is the estimated period of time that options granted are expected to be outstanding. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” employee option grants. Since the Company’s stock has not been publicly traded for a sufficiently long period of time, the Company is utilizing an expected volatility figure based on a review of the historical volatilities, over a period of time, equivalent to the expected life of the instrument being valued, of similarly positioned public companies within its industry. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued. Restricted Stock Units (“RSUs”) On June 3, 2014, the compensation committee of the board of directors of the Company granted to a member of the Company’s advisory board, an RSU award under which the holder has the right to receive 4,035 49,590 1,513 vests 504 shares on each of the next five succeeding three month anniversaries of the grant date On July 14, 2014, the compensation committee of the board of directors granted to George Holmes an RSU under which the holder has the right to receive 44,836 593,180 25 On July 14, 2014, the compensation committee of the board of directors granted to various employees and consultants, RSUs under which the holders have the right to receive 228,500 3,023,055 25 On August 14, 2014, the compensation committee of the board of directors granted to various employees and consultants, RSUs under which the holders have the right to receive 86,823 981,100 In addition, on August 14, 2014, the compensation committee of the board of directors granted two inducement RSU awards to Cesar Johnston, the Company’s Senior Vice President of Engineering. Under the first award, Mr. Johnston has the right to receive 100,000 20,000 1,356,000 On November 13, 2014, the compensation committee of the board of directors granted inducement RSU awards to various employees and consultants, under which the holders have the right to receive 261,686 2,266,201 In addition, on November 13, 2014, the compensation committee of the board of directors granted to various employees and consultants, RSUs under which the holders have the right to receive 5,100 44,166 On December 24, 2014, the compensation committee of the board of directors granted inducement RSU awards to various employees and consultants, under which the holders have the right to receive 77,856 620,512 On December 24, 2014, the compensation committee of the board of directors granted an RSU award to a consultant, under which the holder has the right to receive 5,000 39,850 On January 2, 2015, the compensation committee of the board of directors granted to various directors, RSUs under which the holders have the right to receive an aggregate of 17,576 4,394 On January 22, 2015, the compensation committee of the board of directors granted to various employees and consultants, RSUs under which the holders have the right to receive an aggregate of 54,500 On February 26, 2015, the compensation committee of the board of directors granted to two employees RSUs under which the holders have the right to receive an aggregate of 6,800 On February 26, 2015, the compensation committee of the board of directors granted to Mr. Rizzone, the Company’s Chief Executive Officer, RSUs under which Mr. Rizzone has the right to receive 246,226 On February 26, 2015, the compensation committee of the board of directors granted to a member of the advisory board RSUs under which the holder has the right to receive 5,071 12.5 12.5 On May 21, 2015, the compensation committee of the board of directors granted to various employees and consultants inducement RSU awards under which the holders have the right to receive an aggregate of 205,081 On May 21, 2015, the compensation committee of the board of directors granted to Cesar Johnston, the Company’s Senior Vice President of Engineering, RSUs under which Mr. Johnston has the right to receive 1,500 On May 21, 2015, the compensation committee of the board of directors granted to two consultants RSUs under which the holders have the right to receive an aggregate of 7,042 On May 21, 2015, in connection with patent applications, the compensation committee of the board of directors granted to various employees RSUs under which the holders have the right to receive an aggregate of 6,300 2,100 3,500 700 On May 21, 2015, the compensation committee of the board of directors granted to John Gaulding, director and chairman of the board, RSUs under the 2014 Non-Employee Equity Compensation Plan for which Mr. Gaulding has the right to receive 25,000 On May 21, 2015, the compensation committee of the board of directors accelerated the vesting of 13,074 On July 1, 2015, the Company appointed Martin Cooper to the Board of Directors with a term expiring at the Company’s 2016 annual stockholders meeting. In connection with Mr. Cooper’s appointment to the Board, Mr. Cooper was issued RSUs under the Company’s 2014 Non-Employee Equity Compensation Plan covering a total of 5,061 On July 13, 2015, the Company appointed Brian Sereda Vice President and Chief Financial Officer. As an inducement to join the Company, Mr. Sereda received an inducement restricted stock unit award covering a total of 120,000 On August 20, 2015, the compensation committee of the board of directors granted to three consultants RSUs under which the holders have the right to receive an aggregate of 8,854 1,416 During August 2015, the compensation committee of the board of directors granted to various employees inducement RSU awards under which the holders have the right to receive an aggregate of 74,992 On October 22, 2015, the compensation committee of the board of directors granted to various employees 35,000 50 50 On December 17, 2015, the compensation committee of the board of directors granted Cesar Johnston and Michael Leabman each 12,500 50 50 On December 17, 2015, the compensation committee of the board of directors granted to various employees inducement RSU awards under which the holders have the right to receive an aggregate of 180,098 On December 17, 2015, the compensation committee of the board of directors granted to various employees RSU awards under the 2013 Equity Incentive Plan for promotions and merit increases under which the holders have the right to receive an aggregate of 121,032 120,500 532 On December 17, 2015, the compensation committee of the board of directors granted to three consultants RSUs under which the holders have the right to receive an aggregate of 9,575 1,330 On December 28, 2015, the compensation committee of the board of directors granted a new employee an inducement RSU award under which the holder has the right to receive an aggregate 120,000 The Company accounts for RSUs granted to consultants using the accounting guidance included in ASC 505-50 “Equity-Based Payments to Non-Employees” (“ASC 505-50”). In accordance with ASC 505-50, the Company estimates the fair value of the unvested portion of the RSU award each reporting period using the closing price of the Company’s common stock. At December 31, 2015, the unamortized value of the RSUs was $ 11,513,825 3.2 Weighted Average Grant Total Date Fair Value Outstanding at January 1, 2014 - $ - RSUs granted 837,672 $ 10.75 RSUs forfeited (104,044) $ 12.57 RSUs vested (6,349) $ 9.94 Outstanding at December 31, 2014 727,279 $ 10.49 RSUs granted 1,274,707 $ 8.23 RSUs forfeited (135,199) $ 9.73 RSUs vested (305,791) $ 9.89 Outstanding at December 31, 2015 1,560,996 $ 8.83 Vested at January 1, 2014 - - RSUs vested 6,349 $ 9.94 Shares of common stock issued in exchange for RSUs - $ - Vested at December 31, 2014 6,349 $ 9.94 RSUs vested 305,791 $ 9.89 Shares of common stock issued in exchange for RSUs (304,340) $ Vested at December 31, 2015 7,800 $ 7.94 Performance Share Units (“PSUs”) Effective on May 21, 2015, the compensation committee of the board of directors granted to Stephan Rizzone PSUs under which Mr. Rizzone had the right to receive up to 639,075 On May 21, 2015, the compensation committee of the board of directors granted to its independent directors and executives, PSUs under which the holders have the right to receive up to 543,216 100 1.1 100 100 1.1 On July 1, 2015, the Company appointed Martin Cooper to the Board of Directors with a term expiring at the Company’s 2016 annual stockholders meeting. In connection with Mr. Cooper’s appointment, he was granted PSUs under the Company’s 2015 Performance Share Unit Plan for which he is eligible to receive 31,954 On December 17, 2015, the compensation committee of the board of directors granted to Brian Sereda PSUs under the Company’s 2015 Performance Share Unit Plan for which he is eligible to receive 63,908 The Company determined that the PSUs were equity awards with both market and service conditions. The Company utilized a Monte Carlo simulation to determine the fair value of the market condition, as described below. Grantees of PSUs are required to be employed through December 31, 2018 in order to earn the entire award, if and when vested. Performance Share Market capitalization $ 106,270,000 Dividend yield 0 % Expected volatility 60 % Risk-free interest rate 0.95 % The fair value of the grant of PSUs to purchase a total of 1,278,153 3,351,353 489,239 At December 31, 2015, the unamortized value of the PSUs was approximately $ 2,527,095 3.0 Weighted Average Grant Total Date Fair Value Outstanding at January 1, 2015 - $ - PSUs granted 1,278,153 $ 2.62 PSUs forfeited (127,699) $ 2.62 PSUs vested (14,840) $ 2.62 Outstanding at December 31, 2015 1,135,614 $ 2.62 Vested at January 1, 2015 - $ - PSUs vested 14,840 $ 2.62 Shares of common stock issued in exchange for PSUs (1,072) $ 2.62 Vested at December 31, 2015 13,768 $ 2.62 Employee Stock Purchase Plan (“ESPP”) The initial offering period for the ESPP is July 1, 2015 through December 31, 2015. Through December 31, 2015, employees have contributed an aggregate of $ 289,787 46,023 553,977 The weighted-average grant-date fair value of the purchase option for each designated share purchased under this plan was approximately $ 2.46 113,217 Purchase Options Granted July 1, 2015 Stock price $ 7.41 Dividend yield 0 % Expected volatility 65 % Risk-free interest rate 0.13 % Expected life 6 months Stock-Based Compensation Expense For the Years Ended December 31, 2015 2014 2013 Stock options $ 1,037,399 $ 1,333,943 $ 16,148 RSUs 4,225,728 900,063 - IR warrants 85,831 263,972 - PSUs 489,239 - - ESPP 113,217 - - Shares issued to consultant for services rendered - 50,000 - Total $ 5,951,414 $ 2,547,978 $ 16,148 For the Years Ended December 31, 2015 2014 2013 Research and development $ 2,816,707 $ 924,702 $ - Sales and marketing 729,329 583,238 - General and administrative 2,405,378 1,040,038 16,148 Total $ 5,951,414 $ 2,547,978 $ 16,148

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 10 - Income Taxes December 31, Deferred tax assets (liabilities): 2015 2014 Tax credit $ 2,958,771 $ 877,597 Net operating loss carryovers 7,511,765 2,314,198 Property and equipment (98,235) (20,282) Research and development costs 10,380,961 5,820,399 Start-up and organizational costs 1,333 1,443 Stock-based compensation 1,175,821 448,893 Other accruals 155,472 188,439 Total gross deferred tax assets 22,085,888 9,630,687 Less: valuation allowance (22,085,888) (9,630,687) Deferred tax assets, net $ - $ - 2015 2014 January 1, $ 9,630,687 $ 1,839,611 Increase in valuation allowance 12,455,201 7,791,076 December 31, $ 22,085,888 $ 9,630,687 The Company has a net operating loss carryover of approximately $ 18,872,000 2,041,000 Internal Revenue Code Section 382 imposes limitations on the use of net operating loss carryovers when the stock ownership of one or more 5% shareholders (shareholders owning 5% or more of the Company’s outstanding capital stock) has increased on a cumulative basis by more than 50 percentage points. Management cannot control the ownership changes occurring as a result of public trading of the Company’s Common Stock. Accordingly, there is a risk of an ownership change beyond the control of the Company that could trigger a limitation of the use of the loss carryover. As of December 31, 2015, the Company has not completed an analysis whether an ownership change occurred under Section 382, which, if it did occur, could substantially limit its ability in the future to utilize its net operating loss and other tax carryforwards. For the Year Ended December 31, 2015 2014 Tax benefit at federal statutory rate (34.0) % (34.0) % State income taxes (5.5) (5.8) Permanent difference: Stock-based compensation 1.3 1.1 Meals and entertainment 0.1 - Derivative instrument issuance - financing warrant - - Change in fair value of derivative liability - 22.9 General and administrative expense - consulting warrant - - Amortization of debt discount - 0.8 Gain on debt extinguishment - (1.8) True-up of state deferred taxes (0.2) - Other 0.7 0.6 Research and development tax credit, federal (4.4) (0.9) Research and development tax credit, state (3.1) - Increase in valuation allowance, federal 36.3 17.1 Increase in valuation allowance, state 8.8 - Effective income tax rate 0.0 % 0.0 %

Related Party

Related Party	12 Months Ended
	Dec. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 11 – Related Party On July 14, 2014, the Company’s Board of Directors appointed Howard Yeaton as the Company’s Interim Chief Financial Officer. On July 13, 2015, the Company appointed Brian Sereda as the Company’s Chief Financial Officer, replacing Interim Chief Financial Officer Howard Yeaton. Howard Yeaton is the Managing Principal of Financial Consulting Strategies LLC (“FCS”). During the year ended December 31, 2015, the Company had incurred fees of $ 61,848 88,813

Unaudited Quarterly Financial I

Unaudited Quarterly Financial Information	12 Months Ended
	Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]
Schedule of Quarterly Financial Information [Table Text Block]	Note 12 – Unaudited Quarterly Financial Information Summarized quarterly information for the years ended December 31, 2015 and 2014 is listed below: For the quarter ended March 31 June 30 September 30 December 31 2015 Revenue $ 200,000 $ 225,000 $ 2,075,000 $ - Operating expenses $ 7,131,600 $ 6,374,970 $ 7,683,317 $ 8,887,452 Net loss $ (6,925,279) $ (6,146,582) $ (5,605,661) $ (8,884,180) Loss per share, basic and diluted $ (0.54) $ (0.48) $ (0.43) $ (0.61) 2014 Revenue $ - $ - $ - $ - Operating expenses $ 2,020,533 $ 3,495,023 $ 5,830,438 $ 9,028,715 Net (loss) income $ (31,009,723) $ 278,621 $ (5,847,998) $ (9,024,010) Net (loss) income per share, basic and diluted $ (11.45) $ 0.03 $ (0.62) $ (0.89)

Summary of Significant Accoun21

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”).
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements as well as the reported expenses during the reporting periods. The Company’s significant estimates and assumptions include the valuation of stock-based compensation instruments, recognition of revenue, the useful lives of long-lived assets, and income tax expense. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Although the Company believes that its estimates and assumptions are reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ from those estimates.
Reclassification, Policy [Policy Text Block]	Reclassification Certain amounts in prior periods have been reclassified to conform to the current period presentation. These reclassifications had no effect on previously reported net loss.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents The Company considers all short-term, highly liquid investments with an original maturity at the date of purchase of three months or less to be cash equivalents. The Company maintains cash balances that may be uninsured or in deposit accounts that exceed Federal Deposit Insurance Corporation limits. The Company maintains its cash deposits with major financial institutions.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company recognizes revenue when all of the following criteria have been met: persuasive evidence of an arrangement exists, services have been rendered, collection of the revenue is reasonably assured, and the fees are fixed or determinable. The Company records revenue associated with product development projects that it enters into with certain customers. In general, these projects are associated with complex technology development, and as such the Company does not have certainty about its ability to achieve the program milestones. Achievement of the milestone is dependent on our performance and the milestone typically needs to be accepted by the customer. The payment associated with achieving the milestone is generally commensurate with the Company’s effort or the value of the deliverable and is nonrefundable. The Company records the expenses related to these projects, generally included in research and development expense, in the periods incurred. The Company also receives nonrefundable payments, typically at the beginning of a customer relationship, for which there are no milestones. The Company recognizes this revenue ratably over the initial engineering product development period. The Company records the expenses related to these projects, generally included in research and development expense, in the periods incurred.
Research and Development Expense, Policy [Policy Text Block]	Research and Development Research and development expenses are charged to operations as incurred. For internally developed patents, all patent application costs are expensed as incurred as research and development expense. Patent application costs, generally legal costs, are expensed as research and development costs until such time as the future economic benefits of such patents become more certain. The Company incurred research and development costs of $ 18,825,041 12,511,647 2,109,890
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with accounting guidance that requires awards to be recorded at their fair value on the date of grant and are amortized over the vesting period of the award. The Company recognizes compensation costs on a straight line basis over the requisite service period of the award, which is typically the vesting term of the equity instrument issued. On April 10, 2015, the Company’s board of directors approved the Energous Corporation Employee Stock Purchase Plan (the “ESPP”), under which 600,000 On May 21, 2015, the Company’s stockholders approved the ESPP. Under the plan, employees may purchase a limited number of shares of the Company’s common stock at a 15
Income Tax, Policy [Policy Text Block]	Income Taxes Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of December 31, 2015, no liability for unrecognized tax benefits was required to be reported. The guidance also discusses the classification of related interest and penalties on income taxes. The Company’s policy is to record interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded during the years ended December 31, 2015, 2014 and 2013.
Earnings Per Share, Policy [Policy Text Block]	Net Loss Per Common Share Basic net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and warrants (using the treasury stock method), the vesting of restricted stock units (“RSUs”) and performance stock units (“PSUs”) and the enrollment of employees in the ESPP. The computation of diluted loss per share excludes potentially dilutive securities of 4,994,425 3,261,360 3,525,904 For the Years Ended December 31, 2015 2014 2013 Convertible Notes – principal - - 2,650,858 Convertible Notes – accrued interest - - 100,224 Consulting Warrant to purchase common stock 146,252 278,228 278,228 Financing Warrant to purchase common stock 152,778 152,778 220,905 IPO Warrants to purchase common stock 460,000 460,000 - IR Consulting Warrant 36,000 36,000 - IR Incentive Warrant 15,000 - - Options to purchase common stock 1,487,785 1,607,075 275,689 RSUs 1,560,996 727,279 - PSUs 1,135,614 - - Total potentially dilutive securities 4,994,425 3,261,360 3,525,904
Fair Value Measurement, Policy [Policy Text Block]	Fair Value Measurements The carrying amounts of cash and cash equivalents, accounts payable and accrued expenses, approximate fair value due to the short-term nature of these instruments. Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows: Level 1 Quoted prices in active markets for identical assets or liabilities. Level 2 Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly. Level 3 Significant unobservable inputs that cannot be corroborated by market data. The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. As of December 31, 2014, the Company no longer had financial instruments which were derivative liabilities. For the Year Ended Beginning balance $ 6,277,000 Change in fair value of conversion feature and warrants 26,265,177 Extinguishment of derivative liability upon conversion of Convertible Notes (26,790,177) Extinguishment of derivative liability upon modification of Financing Warrant (1,733,000) Extinguishment of derivative liability upon modification of Consulting Warrant (4,019,000) Ending balance $ - The conversion feature of the Convertible Notes immediately prior to conversion was measured at fair value using a Monte Carlo simulation (which also represented the intrinsic value of the conversion feature) and was classified within Level 3 of the valuation hierarchy. The warrant liabilities for the Financing Warrant and the Consulting Warrant, immediately prior to modification were measured at fair value using a Monte Carlo simulation and were classified within Level 3 of the valuation hierarchy. The significant assumptions and valuation methods that the Company used to determine fair value and the change in fair value of the Company’s derivative financial instruments are discussed in Note 6 – Private Placement. Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Interim Chief Financial Officer determined its valuation policies and procedures. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s Interim Chief Financial Officer with support from the Company’s consultants and which are approved by the Interim Chief Financial Officer. Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. The Company used a Monte Carlo model to value Level 3 financial liabilities at inception and on subsequent valuation dates, except that the conversion feature of the convertible notes immediately prior to conversion was valued at intrinsic value. This simulation incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as, volatility. The Company also used a binomial simulation and Black-Scholes economic model as supplemental valuation tools in order to validate the reasonableness of the results of the Monte Carlo simulation when measuring the Financing Warrant and the Consulting Warrant. A significant increase in the volatility or a significant increase in the Company’s stock price, in isolation, would result in a significantly higher fair value measurement. Changes in the values of the derivative liabilities were recorded in Change in Fair Value of Derivative Liabilities within Other Expense (Income) on the Company’s Statements of Operations. Management determined that the results of its valuations are reasonable.
New Accounting Pronouncements, Policy [Policy Text Block]	In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers" (Topic 606), which supersedes the revenue recognition requirements in ASC Topic 605, "Revenue Recognition," and most industry-specific guidance. This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. The amendments in the ASU must be applied using one of two retrospective methods and are effective for annual and interim periods beginning after December 15, 2016. On July 9, 2015, the FASB modified ASU 2014-09 to be effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. As modified, the FASB permits the adoption of the new revenue standard early, but not before the annual periods beginning after December 15, 2016. A public organization would apply the new revenue standard to all interim reporting periods within the year of adoption. The Company will evaluate the effects, if any, that adoption of this guidance will have on its financial statements. In August 2014, FASB issued ASU No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This standard is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. Under U.S. GAAP, financial statements are prepared under the presumption that the reporting organization will continue to operate as a going concern, except in limited circumstances. Financial reporting under this presumption is commonly referred to as the going concern basis of accounting. The going concern basis of accounting is critical to financial reporting because it establishes the fundamental basis for measuring and classifying assets and liabilities. Currently, U.S. GAAP lacks guidance about management’s responsibility to evaluate whether there is substantial doubt about the organization’s ability to continue as a going concern or to provide related footnote disclosures. This ASU provides guidance to an organization’s management, with principles and definitions that are intended to reduce diversity in the timing and content of disclosures that are commonly provided by organizations today in the financial statement footnotes. The amendments are effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early application is permitted for annual or interim reporting periods for which the financial statements have not previously been issued. The adoption of this standard is not expected to have a material impact on the Company’s financial position and results of operations. In April 2015, the FASB issued ASU No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs." This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of a deferred charge. It is effective for annual reporting periods beginning after December 15, 2015, but early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s financial position and results of operations. In August 2015, the FASB issued ASU No. 2015-15, “Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements” – Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015, which clarified the SEC staff’s position on presenting and measuring debt issuance costs incurred in connection with line-of-credit arrangements. ASU 2015-15 should be adopted concurrent with the adoption of ASU 2015-03. The adoption of this standard is not expected to have a material impact on the Company’s financial position and results of operations. In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes” (“ASU 2015-17”). The standard requires that deferred tax assets and liabilities be classified as noncurrent in a classified statement of financial position. ASU 2015-17 is effective for fiscal years and interim periods within those years, beginning after December 15, 2016. Early adoption is permitted. ASU 2015-17 may be applied either prospectively, for all deferred tax assets and liabilities, or retrospectively. The Company is currently evaluating the impact this standard will have on its financial statements. In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). The standard addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. ASU 2016-01 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company is currently evaluating the impact the adoption of this new standard will have on its financial statements. In January 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842).” (“ASU 2016-02”)
Subsequent Events, Policy [Policy Text Block]	Management’s Evaluation of Subsequent Events The Company evaluates events that have occurred after the balance sheet date of December 31, 2015, through the date which the financial statements are issued. Based upon the review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Summary of Significant Accoun22

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. For the Years Ended December 31, 2015 2014 2013 Convertible Notes – principal - - 2,650,858 Convertible Notes – accrued interest - - 100,224 Consulting Warrant to purchase common stock 146,252 278,228 278,228 Financing Warrant to purchase common stock 152,778 152,778 220,905 IPO Warrants to purchase common stock 460,000 460,000 - IR Consulting Warrant 36,000 36,000 - IR Incentive Warrant 15,000 - - Options to purchase common stock 1,487,785 1,607,075 275,689 RSUs 1,560,996 727,279 - PSUs 1,135,614 - - Total potentially dilutive securities 4,994,425 3,261,360 3,525,904
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	For the Year Ended Beginning balance $ 6,277,000 Change in fair value of conversion feature and warrants 26,265,177 Extinguishment of derivative liability upon conversion of Convertible Notes (26,790,177) Extinguishment of derivative liability upon modification of Financing Warrant (1,733,000) Extinguishment of derivative liability upon modification of Consulting Warrant (4,019,000) Ending balance $ -

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Property and equipment are as follows: As of December 31, 2015 2014 Computer software $ 650,386 $ 459,861 Computer hardware 1,203,021 725,739 Furniture and fixtures 457,887 342,452 Leasehold improvements 593,287 343,734 2,904,581 1,871,786 Less – accumulated depreciation (1,174,216) (356,487) Total property and equipment, net $ 1,730,365 $ 1,515,299

Accrued Expenses (Tables)

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2015
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	Accrued expenses consist of the following: As of December 31, 2015 2014 Accrued compensation $ 739,782 $ 425,824 Other accrued expenses 336,097 366,525 Total $ 1,075,879 $ 792,349

Private Placement (Tables)

Private Placement (Tables)	12 Months Ended
	Dec. 31, 2015
Private Placement [Line Items]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	The Company calculated the fair value of the embedded conversion feature of the Convertible Notes at April 2, 2014 at the conversion features’ fair value, with the observable assumptions as provided in the table below. As of April 2, 2014 Stock price on valuation date $ 13.88 Conversion price $ 3.00 Fair value $ 26,790,177
Financing And Consulting Warrant [Member]
Private Placement [Line Items]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	Provided below are the principal assumptions used in the measurement of the fair values of the Financing Warrant and the Consulting Warrant as of June 24, 2014. As of June 24, 2014 As of December 31, 2013 Financing Consulting Financing Consulting Stock price on valuation date $ 14.69 $ 14.69 $ 1.68 $ 1.68 Exercise price $ 3.60 $ 0.04 $ 2.49 $ 0.04 Term (years) 3.89 3.89 4.38 4.38 Expected volatility 60 % 60 % 60 % 60 % Dividend yield 0 % 0 % 0 % 0 % Weighted average risk-free interest rate 1.33 % 1.33 % 1.75 % 1.75 % Number of warrants 152,778 278,228 220,905 278,228 Number of trials 20,000 20,000 20,000 20,000 Aggregate fair value $ 1,733,000 $ 4,019,000 $ 175,000 $ 529,000

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2015
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	For the Years Ended December 31, Amount 2016 529,309 2017 572,722 2018 530,531 2019 372,652 Total $ 2,005,214

Stock Based Compensation (Table

Stock Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	The Company estimated the fair value of stock options awarded during the year ended December 31, 2014 using the Black-Scholes option pricing model. The fair values of stock options granted were estimated using the following assumptions: Option Grants Awarded During the Year Ended December 31, 2014 Stock price $2.49 to $6.00 Dividend yield 0 % Expected volatility 60 % Risk-free interest rate 1.30% to 2.03% Expected life 3.75 to 6.25 years
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	The following is a summary of the Company’s stock option activity during the year ended December 31, 2015: Weighted Weighted Average Average Remaining Number of Exercise Life In Intrinsic Options Price Years Value Outstanding at January 1, 2015 1,607,075 $ 4.41 9.0 $ 10,467,374 Granted - - - - Exercised (21,786) 3.01 - - Forfeited (97,504) 5.72 - - Outstanding at December 31, 2015 1,487,785 $ 4.43 8.0 $ 5,310,340 Exercisable at December 31, 2015 860,970 $ 4.34 8.0 $ 3,076,767
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	A summary of the activity related to RSUs for the year ended December 31, 2015 is presented below: Weighted Average Grant Total Date Fair Value Outstanding at January 1, 2014 - $ - RSUs granted 837,672 $ 10.75 RSUs forfeited (104,044) $ 12.57 RSUs vested (6,349) $ 9.94 Outstanding at December 31, 2014 727,279 $ 10.49 RSUs granted 1,274,707 $ 8.23 RSUs forfeited (135,199) $ 9.73 RSUs vested (305,791) $ 9.89 Outstanding at December 31, 2015 1,560,996 $ 8.83 Vested at January 1, 2014 - - RSUs vested 6,349 $ 9.94 Shares of common stock issued in exchange for RSUs - $ - Vested at December 31, 2014 6,349 $ 9.94 RSUs vested 305,791 $ 9.89 Shares of common stock issued in exchange for RSUs (304,340) $ Vested at December 31, 2015 7,800 $ 7.94
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]	The Company utilized a Monte Carlo simulation to determine the fair value of the market condition, as described below. Grantees of PSUs are required to be employed through December 31, 2018 in order to earn the entire award, if and when vested. Performance Share Market capitalization $ 106,270,000 Dividend yield 0 % Expected volatility 60 % Risk-free interest rate 0.95 %
Share-based Compensation, Performance Shares Award Outstanding Activity [Table Text Block]	A summary of the activity related to PSUs for the year ended December 31, 2015 is presented below: Weighted Average Grant Total Date Fair Value Outstanding at January 1, 2015 - $ - PSUs granted 1,278,153 $ 2.62 PSUs forfeited (127,699) $ 2.62 PSUs vested (14,840) $ 2.62 Outstanding at December 31, 2015 1,135,614 $ 2.62 Vested at January 1, 2015 - $ - PSUs vested 14,840 $ 2.62 Shares of common stock issued in exchange for PSUs (1,072) $ 2.62 Vested at December 31, 2015 13,768 $ 2.62
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	The Company estimated the fair value of the purchase options granted during the year ended December 31, 2015 using the Black-Scholes option pricing model. The fair values of the purchase options granted were estimated using the following assumptions: Purchase Options Granted July 1, 2015 Stock price $ 7.41 Dividend yield 0 % Expected volatility 65 % Risk-free interest rate 0.13 % Expected life 6 months
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	The following tables summarize total stock-based compensation costs recognized for years ended December 31, 2015, 2014 and 2013: For the Years Ended December 31, 2015 2014 2013 Stock options $ 1,037,399 $ 1,333,943 $ 16,148 RSUs 4,225,728 900,063 - IR warrants 85,831 263,972 - PSUs 489,239 - - ESPP 113,217 - - Shares issued to consultant for services rendered - 50,000 - Total $ 5,951,414 $ 2,547,978 $ 16,148
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]	The total amount of stock-based compensation was reflected within the statements of operations as: For the Years Ended December 31, 2015 2014 2013 Research and development $ 2,816,707 $ 924,702 $ - Sales and marketing 729,329 583,238 - General and administrative 2,405,378 1,040,038 16,148 Total $ 5,951,414 $ 2,547,978 $ 16,148

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	As of December 31, 2015 and 2014, the Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following: December 31, Deferred tax assets (liabilities): 2015 2014 Tax credit $ 2,958,771 $ 877,597 Net operating loss carryovers 7,511,765 2,314,198 Property and equipment (98,235) (20,282) Research and development costs 10,380,961 5,820,399 Start-up and organizational costs 1,333 1,443 Stock-based compensation 1,175,821 448,893 Other accruals 155,472 188,439 Total gross deferred tax assets 22,085,888 9,630,687 Less: valuation allowance (22,085,888) (9,630,687) Deferred tax assets, net $ - $ -
Summary of Valuation Allowance [Table Text Block]	The change in the Company’s valuation allowance is as follows: 2015 2014 January 1, $ 9,630,687 $ 1,839,611 Increase in valuation allowance 12,455,201 7,791,076 December 31, $ 22,085,888 $ 9,630,687
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	For the Year Ended December 31, 2015 2014 Tax benefit at federal statutory rate (34.0) % (34.0) % State income taxes (5.5) (5.8) Permanent difference: Stock-based compensation 1.3 1.1 Meals and entertainment 0.1 - Derivative instrument issuance - financing warrant - - Change in fair value of derivative liability - 22.9 General and administrative expense - consulting warrant - - Amortization of debt discount - 0.8 Gain on debt extinguishment - (1.8) True-up of state deferred taxes (0.2) - Other 0.7 0.6 Research and development tax credit, federal (4.4) (0.9) Research and development tax credit, state (3.1) - Increase in valuation allowance, federal 36.3 17.1 Increase in valuation allowance, state 8.8 - Effective income tax rate 0.0 % 0.0 %

Liquidity and Management Plans

Liquidity and Management Plans (Details Textual) - USD ($)	Apr. 04, 2014	Apr. 02, 2014	Apr. 02, 2014	Mar. 07, 2014	Nov. 30, 2015	Nov. 17, 2015	Apr. 24, 2015	Apr. 30, 2014	Mar. 27, 2014	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Liquidity And Management Plans [Line Items]
Engineering product development																		$ 2,500,000
Net income (numerator for basic and diluted earnings per share)										$ (8,884,180)	$ (5,605,661)	$ (6,146,582)	$ (6,925,279)	$ (9,024,010)	$ (5,847,998)	$ 278,621	$ (31,009,723)	(27,561,702)	$ (45,603,110)	$ (5,521,081)
Cash and Cash Equivalents, at Carrying Value, Total										$ 29,872,564				$ 31,494,592				29,872,564	31,494,592	1,953,780	$ 994
Stock Issued During Period, Shares, New Issues					3,000,005
Proceeds from Issuance of Common Stock																		$ 0	$ 0	200,681
Debt Conversion, Converted Instrument, Shares Issued			1,833,336																1,833,336
Stock Issued During Period Shares Upon Conversion Of Debt Instrument Interest																		96,792
Proceeds from Other Equity	$ 900,000																	$ 0	$ 900,000	0
Payments for Commissions	$ 100,000							$ 100,000
Proceeds From Shelf Registration Debt Or Equity Securities							$ 75,000,000
Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total																		(20,005,734)	(15,606,423)	(3,430,978)
Consummation of Offering Under Shelf Registration [Member]
Liquidity And Management Plans [Line Items]
Stock Issued During Period, Shares, New Issues						3,000,005
Proceeds from Issuance of Common Stock					$ 19,048,456	$ 19,333,032
Proceeds From Shelf Registration Debt Or Equity Securities							$ 75,000,000
Common Stock [Member]
Liquidity And Management Plans [Line Items]
Net income (numerator for basic and diluted earnings per share)																		$ 0	$ 0	$ 0
Stock Issued During Period, Shares, New Issues																			4,600,000
Proceeds from Issuance of Common Stock																			$ 21,000,000
Stock Issued During Period, Shares, Issued for Services	210,527			210,527														15,000	210,527
Proceeds from Other Equity	$ 700,000								$ 300,000
Stock Issued During Period, Shares, Other																		128,480
IPO [Member]
Liquidity And Management Plans [Line Items]
Stock Issued During Period, Shares, New Issues		4,600,000						4,600,000
Proceeds from Issuance of Common Stock								$ 24,800,000
Secondary Offering [Member] | Common Stock [Member]
Liquidity And Management Plans [Line Items]
Stock Issued During Period, Shares, Other																			3,285,714

Summary of Significant Accoun30

Summary of Significant Accounting Policies (Details) - shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	4,994,425	3,261,360	3,525,904
Convertible Notes Principal [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	0	0	2,650,858
Convertible Notes Accrued Interest [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	0	0	100,224
Consulting Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	146,252	278,228	278,228
Financing Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	152,778	152,778	220,905
IPO Warrants [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	460,000	460,000	0
IR Consulting Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	36,000	36,000	0
IR Incentive Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	15,000	0	0
Stock Option [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	1,487,785	1,607,075	275,689
Restricted Stock Units (RSUs) [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	1,560,996	727,279	0
Phantom Share Units (PSUs) [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	1,135,614	0	0

Summary of Significant Accoun31

Summary of Significant Accounting Policies (Details 1)	12 Months Ended
	Dec. 31, 2014USD ($)
Summary Of Significant Accounting Policies [Line Items]
Beginning balance	$ 6,277,000
Ending balance	0
Convertible Notes Payable [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Fair Value Of Derivative Net	26,265,177
Convertible Debt Securities [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Fair Value Of Derivative Net	(26,790,177)
Financing Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Fair Value Of Derivative Net	(1,733,000)
Consulting Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Fair Value Of Derivative Net	$ (4,019,000)

Summary of Significant Accoun32

Summary of Significant Accounting Policies (Details Textual) - USD ($)	Apr. 10, 2015	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]
Research and Development Expense, Total		$ 18,825,041	$ 12,511,647	$ 2,109,890
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		4,994,425	3,261,360	3,525,904
Employee Stock Purchase Plan [Member]
Summary Of Significant Accounting Policies [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	600,000	553,977
Common Stock Purchase Price Discount Percentage	15.00%

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	$ 2,904,581	$ 1,871,786
Less - Accumulated depreciation	(1,174,216)	(356,487)
Total property and equipment, net	1,730,365	1,515,299
Computer Software [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	650,386	459,861
Computer Hardware [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	1,203,021	725,739
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	457,887	342,452
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	$ 593,287	$ 343,734

Property and Equipment (Detai34

Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Depreciation, Depletion and Amortization, Total	$ 817,729	$ 371,189	$ 4,717

Accrued Expenses (Details)

Accrued Expenses (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Schedule of Accrued Liabilities [Line Items]
Accrued Liabilities, Current	$ 1,075,879	$ 792,349
Accrued compensation [Member]
Schedule of Accrued Liabilities [Line Items]
Accrued Liabilities, Current	739,782	425,824
Other accrued expenses [Member]
Schedule of Accrued Liabilities [Line Items]
Accrued Liabilities, Current	$ 336,097	$ 366,525

Private Placement (Details)

Private Placement (Details) - Convertible Notes Payable [Member] - USD ($)	Dec. 31, 2015	Apr. 02, 2014
Private Placement [Line Items]
Stock price on valuation date		$ 13.88
Conversion price	$ 3	$ 3
Fair value		$ 26,790,177

Private Placement (Details 1)

Private Placement (Details 1)	6 Months Ended	12 Months Ended
	Jun. 24, 2014USD ($)Number$ / sharesshares	Dec. 31, 2013USD ($)Number$ / sharesshares	Dec. 31, 2015$ / shares
Consulting Warrant [Member]
Private Placement [Line Items]
Stock price on valuation date	$ 14.69	$ 1.68
Exercise price	$ 0.04	$ 0.04
Term (years)	3 years 10 months 20 days	4 years 4 months 17 days
Expected volatility	60.00%	60.00%
Dividend yield	0.00%	0.00%
Weighted average risk-free interest rate	1.33%	1.75%
Number of warrants | shares	278,228	278,228
Number of trials | Number	20,000	20,000
Aggregate fair value | $	$ 4,019,000	$ 529,000
Financing Warrant [Member]
Private Placement [Line Items]
Stock price on valuation date	$ 14.69	$ 1.68
Exercise price	$ 3.60	$ 2.49	$ 3.60
Term (years)	3 years 10 months 20 days	4 years 4 months 17 days
Expected volatility	60.00%	60.00%
Dividend yield	0.00%	0.00%
Weighted average risk-free interest rate	1.33%	1.75%
Number of warrants | shares	152,778	220,905
Number of trials | Number	20,000	20,000
Aggregate fair value | $	$ 1,733,000	$ 175,000

Private Placement (Details Text

Private Placement (Details Textual) - USD ($)	Apr. 02, 2014	Apr. 02, 2014	Apr. 30, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Aug. 16, 2014	Jun. 24, 2014	May. 16, 2013
Private Placement [Line Items]
Securities Purchase Agreement Initiation Date				May 16, 2013
Debt Instrument, Maturity Date				Aug. 16, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount				4,994,425	3,261,360	3,525,904
Amortization of Debt Discount (Premium)				$ 0	$ 964,851	$ 705,289
Debt Conversion, Converted Instrument, Amount				0	$ 26,790,177	0
Debt Conversion, Converted Instrument, Shares Issued		1,833,336			1,833,336
Debt Instrument, Convertible, Beneficial Conversion Feature				0	$ 21,217,177	197,000
Gains (Losses) on Extinguishment of Debt	$ 2,084,368			0	2,084,368	0
Stock Issued During Period, Value, Conversion of Convertible Securities	$ 26,790,177				26,790,177
Adjustments to Additional Paid in Capital, Other				$ 0	5,752,000	$ 0
Common Stock [Member]
Private Placement [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities				46,023
Stock Issued During Period, Value, Conversion of Convertible Securities					19
Adjustments to Additional Paid in Capital, Other					$ 0
Financing Warrant [Member]
Private Placement [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount				152,778	152,778	220,905
Payments for Fees						$ 538,393
Sale Of Warrants In Cash				$ 1,000
Warrants Aggregate Exercise Price				$ 550,000
Percentage Exercise Price Of Warrants Determined Based On Conversion Price Of Convertible Notes				120.00%
Investment Warrants, Exercise Price				$ 3.60
Percentage Of Warrants Exercise Based On Convertible Notes Conversion Price				120.00%
Fair Value Assumptions, Exercise Price				$ 3.60		$ 2.49		$ 3.60
Consulting Warrant [Member]
Private Placement [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount				146,252	278,228	278,228
Sale Of Warrants In Cash						$ 1,500
Investment Warrants, Exercise Price				$ 0.04
Fair Value Assumptions, Exercise Price						$ 0.04		$ 0.04
Financing And Consulting Warrant [Member]
Private Placement [Line Items]
Increase (Decrease) in Derivative Liabilities					$ 5,048,000	$ 20,000
InterestPayable [Member]
Private Placement [Line Items]
Debt Conversion, Converted Instrument, Amount			$ 290,219
Debt Conversion, Converted Instrument, Shares Issued			96,792
Maximum [Member] | Common Stock [Member]
Private Placement [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities	1,930,128
Convertible Notes Payable [Member]
Private Placement [Line Items]
Debt Instrument, Face Amount									$ 5,500,009
Debt Instrument, Interest Rate, Stated Percentage							6.00%
Debt Instrument, Convertible, Conversion Price	$ 3	$ 3		$ 3
Debt Conversion, Converted Instrument, Amount			$ 5,500,009
Debt Conversion, Converted Instrument, Shares Issued		1,833,336

Commitments and Contingencies39

Commitments and Contingencies (Details)	Dec. 31, 2015USD ($)
Commitments and Contingencies [Line Items]
2,016	$ 529,309
2,017	572,722
2,018	530,531
2,019	372,652
Total	$ 2,005,214

Commitments and Contingencies40

Commitments and Contingencies (Details Textual) - USD ($)	Oct. 05, 2015	Jul. 13, 2015	Jul. 09, 2015	Sep. 10, 2014	Dec. 18, 2015	Jun. 25, 2015	Mar. 23, 2015	Feb. 26, 2015	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Commitments and Contingencies [Line Items]
Investor Relations Agreement, Initiation Date									Jan. 13, 2014
Warrants Issued To Purchase Common Stock, Shares								15,000
Stock based compensation expense									$ 5,951,414	$ 2,547,978	$ 16,148
Operating Leases, Rent Expense			$ 6,376
Cash Compensation For Services Received Per Month 1									8,000
Payments for Tenant Improvements									100,000	100,000
Payments for Rent										400,000
Operating Leases, Rent Expense, Net								$ 4,314
General and Administrative Expense, Total									$ 8,030,995	5,059,703	1,204,896
Operating Leases, Rent Expense, Sublease Rentals								6,109
Employment Agreement Percentage of Base Salary									100.00%
Officers' Compensation									$ 365,000
Performance Based Equity Plan, Market Capitalization Minimum Amount									100,000,000
Performance Based Equity Plan Market Capitalization Maximum Amount									1,100,000,000
Stock Issued During Period, Value, Issued for Services									$ 147,900	$ 900,000	$ 0
Number Of Shares Issued To Landlord As Prepaid Rent And Tenant Improvements				41,563
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period									1,274,707	837,672
Prepaid Rent									$ 80,784	$ 80,784
Chief Commercial Officer [Member]
Commitments and Contingencies [Line Items]
Officers' Compensation	$ 80,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	80,201
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 2.49
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total	44,836
General and Administrative Expense [Member]
Commitments and Contingencies [Line Items]
Amortization Of Prepaid Service Paid In Stocks									$ 147,900
Consulting Agreement [Member]
Commitments and Contingencies [Line Items]
Payments for Fees								$ 5,000
Hosted Design Solution Agreement [Member]
Commitments and Contingencies [Line Items]
Other Cost of Services						$ 100,568
Hardware And Software Configuration Payments Period Increase					$ 198,105
Offer Letter [Member]
Commitments and Contingencies [Line Items]
Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage		75.00%
Percentage of Vesting Related To Liquidation Or Termination		100.00%
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		120,000
Employee Stock Option [Member]
Commitments and Contingencies [Line Items]
Deferred Compensation Arrangement with Individual, Exercise Price									$ 1.68
Deferred Compensation Arrangement with Individual, Maximum Contractual Term									48 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross									0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price									$ 0
Licensing Agreements [Member]
Commitments and Contingencies [Line Items]
Research and Development Arrangement, Contract to Perform for Others, Compensation Earned							$ 500,000
Development And Licensing Agreements [Member]
Commitments and Contingencies [Line Items]
Revenue Recognition, Milestone Method, Revenue Recognized									$ 2,000,000
Performance-Based Equity Plan [Member]
Commitments and Contingencies [Line Items]
Percentage Of Performance Share Units To Be Earned On Achievement Of Market Capitalization Growth									100.00%
Percentage Of Performance Share Units To Be Paid On Quarterly Basis									50.00%
Percentage Of Performance Share Units To Be Paid On Termination of Employment Agreement									25.00%
Performance Based Equity Plan, Market Capitalization Minimum Amount									$ 100,000,000
Performance Based Equity Plan Market Capitalization Maximum Amount									$ 1,100,000,000
Percentage Of Performance Share Units Deferred									50.00%
Performance-Based Equity Plan [Member] | Phantom Share Units (PSUs) [Member]
Commitments and Contingencies [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross									639,075
Second Employee Stock Option [Member]
Commitments and Contingencies [Line Items]
Deferred Compensation Arrangement with Individual, Exercise Price									$ 6
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross									496,546
Term Leases [Member]
Commitments and Contingencies [Line Items]
Payments for Tenant Improvements									$ 100,000
Balzer Family Investments, L.P [Member]
Commitments and Contingencies [Line Items]
Operating Leases, Rent Expense				$ 36,720
Operating Leases Expiration Period				60 months
Operating Leases, Rent Expense, Net				$ 6,732
Mr. Sereda [Member] | Offer Letter [Member]
Commitments and Contingencies [Line Items]
Officers' Compensation		$ 250,000
Mr. Rizzone [Member] | Employee Stock Option [Member]
Commitments and Contingencies [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross									275,689
Common Stock [Member]
Commitments and Contingencies [Line Items]
Payments for Rent				400,000
Shares Issued To Landlord As Prepaid Rent And Tenant Improvements Value				$ 500,000
Common Stock [Member] | Consulting Agreement [Member]
Commitments and Contingencies [Line Items]
Stock Issued During Period, Shares, Issued for Services								15,000
Stock Issued During Period, Value, Issued for Services								$ 147,900
IR Consulting Warrant [Member]
Commitments and Contingencies [Line Items]
Warrants Issued To Purchase Common Stock, Shares									36,000
Investment Warrants, Exercise Price									$ 7.80
Warrants Exercise Price, Representing IPO Price Percentage									130.00%
Warrants Vesting, Each Month Of Service									3,000
Warrants Vesting Thereafter, Each Month Of Service									3,000
Warrant Vested During Period, Shares									36,000	34,800
Stock based compensation expense									$ 7,522	$ 263,972
IR Incentive Warrant [Member]
Commitments and Contingencies [Line Items]
Warrants Issued To Purchase Common Stock, Shares								15,000
Investment Warrants, Exercise Price								$ 7.80
Warrant Vested During Period, Shares										15,000
Stock based compensation expense								$ 78,309
Terms Of Incentive Warrant Market Maker								$ 250,000
General and Administrative Expense, Total										$ 92,000
IR Consulting And Incentive Warrant [Member]
Commitments and Contingencies [Line Items]
Warrants Term									4 years

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	Apr. 11, 2015	Dec. 15, 2014	Apr. 04, 2014	Apr. 02, 2014	Mar. 07, 2014	Nov. 30, 2015	Nov. 17, 2015	Apr. 24, 2015	Apr. 30, 2014	Mar. 27, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Mar. 26, 2014
Class of Stock [Line Items]
Common Stock, Shares Authorized											50,000,000	50,000,000		60,000,000
Preferred Stock, Shares Authorized											10,000,000	10,000,000		10,000,000
Stock Issued During Period, Shares, New Issues						3,000,005
Proceeds from Issuance Initial Public Offering											$ 0	$ 24,872,170	$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount											4,994,425	3,261,360	3,525,904
Sale of Stock, Price Per Share					$ 0.0001
Proceeds from Other Equity			$ 900,000								$ 0	$ 900,000	$ 0
Payments for Commissions			100,000						$ 100,000
Payments of Stock Issuance Costs												2,816,149
Stock Issued During Period, Value, Other											0
Proceeds From Shelf Registration Debt Or Equity Securities								$ 75,000,000
Proceeds From Disgorgement Of Short Swing Profit	$ 12,611										12,611	0	0
Proceeds from Issuance of Common Stock											$ 0	$ 0	$ 200,681
Consummation of Offering Under Shelf Registration [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues							3,000,005
Common Stock, Discount on Shares							$ 1,242,002
Proceeds From Shelf Registration Debt Or Equity Securities								$ 75,000,000
Stock Offering Expenses On Issue Of Common Stock							125,000
Additional Stock Offering Expenses On Issue Of Common Stock							284,576
Proceeds From Issuance Of Common Stock Net Off Offering Expenses And Discount							$ 19,048,456
Share Price							$ 6.90
Proceeds from Issuance of Common Stock						$ 19,048,456	$ 19,333,032
Common Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues												4,600,000
Proceeds from Issuance or Sale of Equity			$ 1,000,000		$ 1,000,000
Stock Issued During Period, Shares, Issued for Services			210,527		210,527						15,000	210,527
Proceeds from Other Equity			$ 700,000							$ 300,000
Stock Issued During Period, Value, Other											$ 1
Proceeds from Issuance of Common Stock												$ 21,000,000
IPO [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				4,600,000					4,600,000
Shares Issued, Price Per Share				$ 6
Proceeds from Issuance or Sale of Equity				$ 25,214,596
Payments for Underwriting Expense				177,404
Proceeds from Issuance Initial Public Offering		$ 20,993,759		24,783,851
Common Stock, Discount on Shares				2,208,000
Payments of Stock Issuance Costs				$ 430,745
Proceeds from Issuance of Common Stock									$ 24,800,000
Over-Allotment Option [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				600,000
Secondary Offering [Member]
Class of Stock [Line Items]
Proceeds from Issuance or Sale of Equity		$ 21,239,998
Sale of Stock, Price Per Share		$ 7
Stock Issued During Period, Value, Other		$ 3,285,714
Secondary Offering [Member] | Underwriter [Member]
Class of Stock [Line Items]
Payments for Underwriting Expense		150,000
Common Stock, Discount on Shares		1,610,000
Payments of Stock Issuance Costs		$ 246,239
Initial Public Offering Warrant [Member]
Class of Stock [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount											460,000
Investment Warrants, Exercise Price											$ 7.50

Stock Based Compensation (Detai

Stock Based Compensation (Details) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%
Expected volatility	60.00%
Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield		0.00%
Expected volatility		60.00%
Risk-free interest rate, Minimum		1.30%
Risk-free interest rate, Maximum		2.03%
Minimum [Member] | Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price		$ 2.49
Expected life		3 years 9 months
Maximum [Member] | Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price		$ 6
Expected life		6 years 3 months

Stock Based Compensation (Det43

Stock Based Compensation (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Weighted Average Grant Date Fair Value, Forfeited
Intrinsic Value, Exercised	$ 92,728	$ 0
Employee Stock Option [Member]
Weighted Average Grant Date Fair Value, Forfeited
Number of Options, Outstanding	1,607,075
Number of Options, Granted	0
Number of Options, Exercised	(21,786)
Number of Options, Forfeited	(97,504)
Number of Options, Outstanding	1,487,785	1,607,075
Number of Options, Exercisable	860,970
Weighted Average Exercise Price, Outstanding	$ 4.41
Weighted Average Exercise Price, Granted	0
Weighted Average Exercise Price, Exercised	3.01
Weighted Average Exercise Price, Forfeited	5.72
Weighted Average Exercise Price, Outstanding	4.43	$ 4.41
Weighted Average Exercise Price, Exercisable	$ 4.34
Weighted Average Remaining Life In Years, Outstanding	8 years	9 years
Weighted Average Remaining Life In Years, Exercisable	8 years
Intrinsic Value, Outstanding	$ 10,467,374
Intrinsic Value, Exercised	0
Intrinsic Value, Outstanding	5,310,340	$ 10,467,374
Intrinsic Value, Exercisable	$ 3,076,767

Stock Based Compensation (Det44

Stock Based Compensation (Details 2) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning Balance	727,279	0
RSUs granted	1,274,707	837,672
RSUs forfeited	(135,199)	(104,044)
RSUs vested	(305,791)	(6,349)
Outstanding at December 31, 2014	1,560,996	727,279
Weighted Average Grant Date Fair Value, Beginning Balance	$ 10.49	$ 0
Weighted Average Grant Date Fair Value, RSUs granted	8.23	10.75
Weighted Average Grant Date Fair Value, RSUs forfeited	9.73	12.57
Weighted Average Grant Date Fair Value, RSUs vested	9.89	9.94
Weighted Average Grant Date Fair Value, Ending Balance	$ 8.83	$ 10.49
Vested Beginning Balance	6,349	0
RSUs	305,791	6,349
Shares of common stock issued in exchange for RSUs	(304,340)	0
Vested Ending Balance	7,800	6,349
Weighted Average Grant Date Fair Value, Vested Beginning Balance	$ 9.94	$ 0
Weighted Average Grant Date Fair Value, Shares of common stock issued in exchange for RSUs	0	0
Weighted Average Grant Date Fair Value, Vested Ending Balance	$ 7.94	$ 9.94

Stock Based Compensation (Det45

Stock Based Compensation (Details 3)	12 Months Ended
	Dec. 31, 2015USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Market capitalization	$ 106,270,000
Dividend yield	0.00%
Expected volatility	60.00%
Risk-free interest rate	0.95%

Stock Based Compensation (Det46

Stock Based Compensation (Details 4) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested Beginning Balance	6,349	0
Vested Ending Balance	7,800	6,349
Weighted Average Grant Date Fair Value, PSUs granted		$ 2.60
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options, Outstanding	0
PSUs granted	1,278,153
PSUs forfeited	(127,699)
PSUs vested	(14,840)
Number of Options, Outstanding	1,135,614	0
Vested Beginning Balance	0
Shares of common stock issued in exchange for PSUs	(1,072)
Vested Ending Balance	13,768	0
Weighted Average Grant Date Fair Value, Outstanding	$ 0
Weighted Average Grant Date Fair Value, PSUs granted	2.62
Weighted Average Grant Date Fair Value, PSUs forfeited	2.62
Weighted Average Grant Date Fair Value, PSUs vested	2.62
Weighted Average Grant Date Fair Value, Outstanding	2.62	$ 0
Weighted Average Grant Date Fair Value, Vested at January 1, 2015	0
Weighted Average Grant Date Fair Value, Shares of common stock issued in exchange for PSUs	2.62
Weighted Average Grant Date Fair Value, Vested at January 1, 2015	$ 2.62	$ 0

Stock Based Compensation (Det47

Stock Based Compensation (Details 5)	12 Months Ended
	Dec. 31, 2015$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%
Expected volatility	60.00%
Risk-free interest rate	0.95%
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price	$ 7.41
Dividend yield	0.00%
Expected volatility	65.00%
Risk-free interest rate	0.13%
Expected life	6 months

Stock Based Compensation (Det48

Stock Based Compensation (Details 6) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based Compensation, Total	$ 5,951,414	$ 2,547,978	$ 16,148
Shares Issued To Consultant For Services [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	0	50,000	0
IR Consulting Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	85,831	263,972	0
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	4,225,728	900,063	0
Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	489,239	0	0
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	113,217	0	0
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	$ 1,037,399	$ 1,333,943	$ 16,148

Stock Based Compensation (Det49

Stock Based Compensation (Details 7) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based Compensation, Total	$ 5,951,414	$ 2,547,978	$ 16,148
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	2,816,707	924,702	0
Sales and Marketing Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	729,329	583,238	0
General and Administrative Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	$ 2,405,378	$ 1,040,038	$ 16,148

Stock Based Compensation (Det50

Stock Based Compensation (Details Textual) - USD ($)

Jul. 13, 2015

Jan. 02, 2015

Dec. 28, 2015

Dec. 17, 2015

Oct. 22, 2015

Aug. 20, 2015

Jun. 23, 2015

May. 21, 2015

Feb. 26, 2015

Jan. 22, 2015

Dec. 31, 2014

Nov. 30, 2014

Aug. 31, 2014

Jul. 31, 2014

Mar. 31, 2015

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Apr. 10, 2015

Dec. 24, 2014

Nov. 13, 2014

Aug. 14, 2014

Jul. 14, 2014

Mar. 26, 2014

Mar. 15, 2014

Mar. 06, 2014

Feb. 27, 2014

Jan. 07, 2014

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

1,274,707

837,672

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

305,791

6,349

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

4 years

Performance Based Equity Plan Market Capitalization Minimum Amount

$ 100,000,000

Performance Based Equity Plan Market Capitalization Maximum Amount

$ 1,100,000,000

Share based Compensation Arrangement By Share based Payment Award Options Grants In Period Fair Value

3,351,353

Adjustments to Additional Paid in Capital, Other

$ 0

$ 5,752,000

$ 0

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value

$ 8.23

$ 10.75

Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period

304,340

0

Share Based Compensation Arrangement By Share Based Payment Award Unamortized Value

$ 2,527,095

Share Based Compensation Arrangement By Share Based Payment Award Unamortized Weighted Average Period

3 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

$ 92,728

$ 0

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

$ 2.60

Performance Based Equity Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Performance Based Equity Plan Market Capitalization Minimum Amount

100,000,000

Performance Based Equity Plan Market Capitalization Maximum Amount

$ 1,100,000,000

Percentage Of Performance Share Units To Be Earned On Achievement Of Market Capitalization Growth

100.00%

Non-Employee Equity Compensation Plan 2014 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

250,000

Common Stock Available To Be Issued

136,808

2013 Equity Incentive Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

1,042,167

Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)

2,335,967

Common Stock To Be Issued

185,827

2013 Equity Incentive Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant

31,951

Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

35,000

7,042

5,071

5,100

228,500

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

$ 44,166

$ 981,100

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

50.00%

0.00%

12.50%

12.50%

Share based Compensation Arrangement By Share based Payment Award Vesting Rights Remaining Percentage

50.00%

0.00%

Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized

121,032

Restricted Stock Units (RSUs) [Member] | Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

12,500

Restricted Stock Units (RSUs) [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

12,500

Restricted Stock Units (RSUs) [Member] | Share-based Compensation Award, Tranche One [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

3,500

Restricted Stock Units (RSUs) [Member] | Share-based Compensation Award, Tranche Two [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

700

Restricted Stock Units (RSUs) [Member] | Vesting in Four Years [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized

120,500

Restricted Stock Units (RSUs) [Member] | Immidiate Vesting [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized

532

Restricted Stock Units (RSUs) [Member] | Non-Employee Equity Compensation Plan 2014 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award

vests 504 shares on each of the next five succeeding three month anniversaries of the grant date

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

9,575

4,035

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

$ 49,590

$ 49,590

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

1,513

Restricted Stock Units (RSUs) [Member] | 2013 Equity Incentive Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

2,100

Employees And Consultants [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

205,081

54,500

77,856

261,686

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

$ 620,512

$ 2,266,201

$ 3,023,055

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

13,074

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

25.00%

Mr.Michael Leabman [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

251,474

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 6

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vests 6/48th of the award on the grant date and 1/48th of the award on the last day of each of the subsequent 42 months

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

$ 844,643

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Mr. George Holmes [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

89,672

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 6

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Mr. George Holmes [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

44,836

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

$ 593,180

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

25.00%

Two New Independent Directors [Member] | Non-Employee Equity Compensation Plan 2014 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

34,781

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 5.45

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

$ 100,000

Mr. Rizzone [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

496,546

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 6

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vests 6/48 of the award on the grant date and 1/48 of the award on the last day of each of the subsequent 42 months

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

1,667,784

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Mr. Rizzone [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

246,226

Employee [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

6,800

Employee [Member] | Restricted Stock Units (RSUs) [Member] | Equity Incentive Plan 2013 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

6,300

Consultant [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vested 25% of the award on September 30, 2014 and continues to vest 1/48th of the award on the last day of each of the subsequent 36 months

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

$ 303,869

Consultant [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

5,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

$ 39,850

Mr. Cesar Johnston | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

100,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

$ 1,356,000

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

4 years

Director [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

17,576

74,992

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

4,394

Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized

120,000

180,098

Mr. Johnston [Member] | Restricted Stock Units (RSUs) [Member] | Equity Incentive Plan 2013 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

1,500

Mr. Gaulding [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

25,000

Martin Cooper [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1,416

Martin Cooper [Member] | Restricted Stock Units (RSUs) [Member] | Non-Employee Equity Compensation Plan 2014 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

1,330

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value

$ 5,061

Brian Sereda [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value

$ 120,000

Three Consultants [Member] | Restricted Stock Units (RSUs) [Member] | Non-Employee Equity Compensation Plan 2014 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value

$ 8,854

Stock Plan 2013 [Member] | Employees And Consultants [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

537,845

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 2.49

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Stock Plan 2013 [Member] | Mr.Michael Leabman [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

57,644

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

3/48ths on the date of grant, and will vest 1/48th monthly over the following 45 months

Stock Plan 2013 [Member] | Mr. George Holmes [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

80,201

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vested 25% on October 1, 2014 and then continues to vest 1/48th of the initial award monthly for the subsequent 36 months.

Stock Plan 2013 [Member] | Other Employees And Consultants [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

319,799

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vest 25% of the award on the later of the first anniversary of the date they started working for the Company or October 1, 2014 and then will vest 1/48th of the initial award monthly for the following 36 months

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

$ 762,699

Stock Plan 2013 [Member] | Two New Independent Directors [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

25,979

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 3.63

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vest 25% on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

$ 100,000

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Employee Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options

$ 1,676,416

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

1 year 9 months 18 days

Employee Stock Option [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

86,823

Performance Shares [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1,278,153

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

$ 2.62

Performance Shares [Member] | Mr. Cesar Johnston | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

20,000

Performance Shares [Member] | Martin Cooper [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

31,954

Performance Shares [Member] | Brian Sereda [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period

63,908

Performance Share Units [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

1,310,104

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

3 years 2 months 12 days

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options

$ 11,513,825

Allocated Share-based Compensation Expense

$ 489,239

$ 0

$ 0

Amortization of Financing Costs

489,239

Performance Share Units [Member] | Performance Based Equity Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

639,075

Performance Share Units [Member] | Mr. Rizzone [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

639,075

Performance Share Units [Member] | Director [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

543,216

Employee Stock Purchase Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award

On May 21, 2015, the Companys stockholders approved the ESPP. Employees may designate an amount not less than 1% but not more than 10% of their annual compensation, but for not more than 7,500 shares during an offering period. An offering period shall be six months in duration commencing on or about January 1 and July 1 of each year. The exercise price of the option will be the lesser of 85% of the fair market of the common stock on the first business day of the offering period and 85% of the fair market value of the common stock on the applicable exercise date.

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

46,023

Allocated Share-based Compensation Expense

$ 113,217

$ 0

$ 0

Adjustments to Additional Paid in Capital, Other

$ 289,787

Common Stock, Capital Shares Reserved for Future Issuance

553,977

600,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value

$ 2.46

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant

553,977

Employee Contribution Through Payroll Withholdings

$ 289,787

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Deferred tax assets (liabilities):
Tax credit	$ 2,958,771	$ 877,597
Net operating loss carryovers	7,511,765	2,314,198
Property and equipment	(98,235)	(20,282)
Research and development costs	10,380,961	5,820,399
Start-up and organizational costs	1,333	1,443
Stock-based compensation	1,175,821	448,893
Other accruals	155,472	188,439
Total gross deferred tax assets	22,085,888	9,630,687
Less: valuation allowance	(22,085,888)	(9,630,687)	$ (1,839,611)
Deferred tax assets, net	$ 0	$ 0

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Tax Contingency [Line Items]
January 1	$ 9,630,687	$ 1,839,611
Increase in valuation allowance	12,455,201	7,791,076
December 31	$ 22,085,888	$ 9,630,687

Income Taxes (Details 2)

Income Taxes (Details 2)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Tax Contingency [Line Items]
Tax benefit at federal statutory rate	(34.00%)	(34.00%)
State income taxes	(5.50%)	(5.80%)
Permanent difference:
Stock-based compensation	1.30%	1.10%
Meals and entertainment	0.10%	0.00%
Derivative instrument issuance - financing warrant	0.00%	0.00%
Change in fair value of derivative liability	0.00%	22.90%
General and administrative expense - consulting warrant	0.00%	0.00%
Amortization of debt discount	0.00%	0.80%
Gain on debt extinguishment	0.00%	(1.80%)
True-up of state deferred taxes	(0.20%)	0.00%
Other	0.70%	0.60%
Effective income tax rate	0.00%	0.00%
Domestic Tax Authority [Member]
Permanent difference:
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent	(4.40%)	(0.90%)
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	36.30%	17.10%
State and Local Jurisdiction [Member]
Permanent difference:
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent	(3.10%)	0.00%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	8.80%	0.00%

Income Taxes (Details Textual)

Income Taxes (Details Textual)	12 Months Ended
	Dec. 31, 2015USD ($)
Income Tax Contingency [Line Items]
Operating Loss Carryforwards	$ 18,872,000
Deferred Tax Assets, Tax Credit Carryforwards, Research	$ 2,041,000
Tax Credit Carry forward Expiration Period	2,032
Operating Loss Carryforwards, Limitations on Use	stock ownership of one or more 5% shareholders (shareholders owning 5% or more of the Company’s outstanding capital stock) has increased on a cumulative basis by more than 50 percentage points.

Related Party (Details Textual)

Related Party (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Salaries, Wages and Officers' Compensation, Total		$ 68,413
Financial Services Costs, Total		$ 126,153
Howard Yeatons Service [Member]
Related Party Transaction [Line Items]
Payments for Fees	$ 61,848
Other Financial Advisory and Accounting Services [Member]
Related Party Transaction [Line Items]
Payments for Fees	$ 88,813

Unaudited Quarterly Financial56

Unaudited Quarterly Financial Information (Details) - USD ($)	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues	$ 0	$ 2,075,000	$ 225,000	$ 200,000	$ 0	$ 0	$ 0	$ 0	$ 2,500,000	$ 0	$ 0
Operating expenses	8,887,452	7,683,317	6,374,970	7,131,600	9,028,715	5,830,438	3,495,023	2,020,533	30,077,339	20,374,709	4,435,470
Net Income (Loss) Attributable to Parent, Total	$ (8,884,180)	$ (5,605,661)	$ (6,146,582)	$ (6,925,279)	$ (9,024,010)	$ (5,847,998)	$ 278,621	$ (31,009,723)	$ (27,561,702)	$ (45,603,110)	$ (5,521,081)
Net (loss) income per share, basic and diluted	$ (0.61)	$ (0.43)	$ (0.48)	$ (0.54)	$ (0.89)	$ (0.62)	$ 0.03	$ (11.45)	$ (2.07)	$ (5.75)	$ (2.11)